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ABSTRACT OF DISSERTATION

INVESTIGATION OF THE PHYSIOLOGICAL ROLE OF RIN GTPASE IN CELL
DEATH, AXONAL INJURY, AND INFLAMMATION FOLLOWING TRAUMATIC
BRAIN INJURY

Traumatic brain injury (TBI) is a progressive disorder, in which the primary
injury results in the initiation of a complex cascade of secondary biochemical and
metabolic changes resulting in lasting neurological dysfunction and cognitive
impairment. The heterogeneous nature of the disease has complicated the
development of pharmacological agents to improve the outcomes of TBI; to date,
no therapeutic treatment has been shown to be effective in clinical trials.
Treatments targeting multiple secondary outcomes (cell death, axonal
degeneration, and inflammation) may provide enhanced therapeutic efficacy
following TBI.
Small Ras family GTP-binding proteins govern diverse cellular processes
by directing the relay of extracellular stimuli to the activation of select intracellular
signaling pathways. Rin (RIT2) is a member of the Rit subfamily of Ras-related
family of GTPases, and is expressed solely within neurons of the CNS. Early cell
culture models demonstrated that Rin signaled upstream of the stress-activated
protein kinase, p38, and lacked the transformative abilities displayed by other
members of the Ras family, suggesting functions for Rin other than cell growth
and proliferation.
To begin to define the physiological function of Rin, we generated a RIT2
knockout mouse and examined the impact of Rin loss in the CNS following brain
trauma. Our data demonstrates that Rin deficiency is neuroprotective following a
controlled cortical impact (CCI) injury, reducing both acute hippocampal
neurodegeneration and promoting sustained neuronal survival, without affecting
post-CCI neurogenesis. Hippocampal neuroprotection achieved by Rin loss was
accompanied by improved cognitive function in injured mice. Furthermore, we
demonstrated that Rin loss led to blunting of axonal degeneration and microglial
activation in the optic nerve following optic nerve stretch injury. The molecular
interaction between Rin and dual leucine zipper kinase suggested a potential role
for Rin in the regulation of a novel stress MAPK-dependent neuronal death

cascade. Lastly, we demonstrated through diffuse closed head injury, that Rin
loss mitigates cytokine release as a result of injury without altering glial
activation.
Together, these studies establish Rin as a novel regulator of neuronal cell
death, cognitive decline, axonal degeneration, and cytokine production following
traumatic brain injury.
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CHAPTER ONE

Background and Introduction

Traumatic Brain Injury
Epidemiology and Etiology
Traumatic brain injury (TBI) is broadly defined as any blow or jolt to the
head that results in damage to the brain and disruption of normal brain function
(CDC 2015). TBI is a leading cause of death and permanent disability worldwide;
there are approximately 57 million people living that have been hospitalized for
TBI around the globe (Murray 1996). In the United States alone, TBI affects 1.5
million people annually (Thurman 1999). As a result of these injuries, 1.1 million
people visit the ER, 235,000 people are hospitalized, and 50,000 will perish
(Thurman 1999, Langlois, Rutland-Brown et al. 2006). Despite these substantial
numbers, TBI statistics are underrepresented, as surveys do not include cases
treated in outpatient settings, physicians’ offices or military facilities in the United
States or abroad (Langlois, Rutland-Brown et al. 2006, Summers, Ivins et al.
2009).
TBI is not constrained to any particular age, gender, or demographic, thus
has the potential to affect everyone. The overall leading causes of TBI are falls
(32%), motor vehicle accidents (19%), struck by/against events (18%), and
assaults (10%) (Rutland-Brown, Langlois et al. 2006). When age is factored into
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the equation, clear trends are observed throughout the life course. It can be seen
that the peak incidence rates in young adults are due to motor vehicle accidents,
whereas in the elderly peak rates are the result of falls (Thurman 1999). Finally,
although both genders are affected, the rates of TBI among males are
significantly higher than those observed in females (650.9 per 100,000 compared
to 429.1 per 100,000). The highest incidence rate of TBI has been reported in
males between the ages of 20 and 30 years (Langlois, Rutland-Brown et al.
2006, Rutland-Brown, Langlois et al. 2006).
TBI is referred to as the invisible epidemic because the long-term effects
of the disease are not always visually apparent. Long-term disabilities resulting
from brain injury include alterations in cognition, mood and personality. TBI has
also been associated with increased risks of other health problems; indeed,
compared to the general population, those who have suffered from TBI are more
likely to experience epilepsy or binge drinking behavior, and are 7.5% more likely
to die within three years of the head injury (Horner, Ferguson et al. 2005,
Selassie, McCarthy et al. 2005, Langlois, Rutland-Brown et al. 2006).
Additionally, TBI has also been associated with increased prevalence rates of
depression and Alzheimer’s disease (Plassman, Havlik et al. 2000, Holsinger,
Steffens et al. 2002). Furthermore, military soldiers returning from Iraq who had
suffered a mild head injury displayed a strong comorbidity of depression and/or
post-traumatic stress disorder (Hoge, McGurk et al. 2008). Overall, it is estimated
that 5.3 million people (approximately 2% of the population) in the United States
alone are living with a permanent TBI-related disability (Thurman 1999). The
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annual cost of care and rehabilitation for TBI sufferers within the United States
was calculated at over $76 billion in 2000 (Finkelstein 2006, Coronado, Xu et al.
2011).
Pathophysiology
The clinical manifestations of TBI are heterogeneous, ranging from a mild
headache or concussion to coma and/or death. Clinically TBI is defined as an
alteration in brain function that could include any of the following: loss of
consciousness, memory loss of events before or after the injury, neurological
defects, sensory loss, loss of balance or coordination, or altered mental state
such as confusion or disorientation (Menon, Schwab et al. 2010). Alterations in
cognition is one of the most commonly reported functional impairments following
TBI (Lundin, de Boussard et al. 2006). Regardless, both cognitive and motor
deficits have been reported to persist months following the initial insult in 40% of
patients (Satz, Forney et al. 1998).
To evaluate the diverse outcomes of a TBI, the Glasgow Coma Score
(GCS) was introduced in the late 1970s to gage the severity of a head injury.
GCS scores fall on a scale from 3 to 15 judging by the ability of a patient to
respond to verbal, auditory, and visual stimuli along with an assessment of motor
and verbal proficiencies (Teasdale and Jennett 1974). Based on this scale, a
patient with a GCS score ranging from 13-15 is classified to have a mild TBI, 912 a moderate TBI, and 3-8 a severe head injury. Nevertheless, patients
presenting with the same GCS score often have vastly different injuries and
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require distinctive treatment methods. More recently, utilization of neuroimaging
techniques, such as magnetic resonance imaging and computerized tomography,
has further advanced characterization of TBI to allow for more appropriate
treatment intervention (Marshall, Marshall et al. 1992, Maas, Steyerberg et al.
2007).
TBI results in the activation of a multitude of pathological outcomes. These
mechanisms set forth by traumatic injury can be separated into primary and
secondary injury events. The primary injury results from the initial mechanical
force to the head. Damage from the mechanical force then triggers the activation
of secondary injury cascades (Figure 1.1).
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Figure 1.1 Progression of primary and secondary injury following insult to
the head. A primary mechanical force to the head results in tissue deformation
and cell shearing within seconds to minutes of the insult results in the activation
of secondary cascades that can persist for months. Together, the primary and
secondary injuries lead to functional deficits. Modified from (Xiong, Mahmood et
al. 2013).
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Primary Injury
The primary injury results in shearing, compression and/or stretching of
nervous system cells and vasculature along with a disruption of membrane
integrity following the application of a mechanical force to the head (Beauchamp,
Mutlak et al. 2008). This initial mechanical disruption can be caused by a variety
of injury mechanisms including: contact with a penetrating or non-penetrating
object, rapid acceleration/deceleration forces, or a blast injury (Menon, Schwab
et al. 2010).
Depending on the type of force, primary injury can be classified as either
focal or diffuse. Focal damage is localized to a discrete area of the brain and
associated with mass lesion formation often caused by contusion and/or
hemorrhage, which leads to localized cell death and ischemia (Povlishock and
Katz 2005). Contrarily, diffuse injury occurs in non-discrete areas across the
brain and is often characterized by edema and axonal injury (Povlishock and
Katz 2005). In either case, the tissue damage and cell death caused by the
primary insult do not lend themselves for therapeutic intervention, instead they
initiate a cascade of detrimental consequences (Beauchamp, Mutlak et al. 2008,
Maas, Roozenbeek et al. 2010).
Secondary Injury Cascades
Secondary injury is defined by the self-propagating pathological alterations
occurring in cells and tissues that result in cellular dysfunction and death hours to
weeks following the initial insult (Borgens and Liu-Snyder 2012). Secondary
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cascades are characterized by a complex set of biochemical and molecular
alterations giving rise to neuroinflammation, delayed cell apoptosis or necrosis,
and edema for prolonged periods following injury (Beauchamp, Mutlak et al.
2008). The nature of secondary injury processes that manifests is dependent
upon the type and severity of the primary injury. Furthermore, secondary injuries
are complex, propagating spatially and temporally following trauma. Disruption of
cellular integrity results in a loss of ion homeostasis as extracellular calcium ions
flow into damaged neurons. This unregulated flow of calcium into the neuron
initiates uncontrolled release of neurotransmitters along with the activation of
intracellular proteases, such as calpain, inducing excitotoxicity and disruption of
cellular transport (Baker, Moulton et al. 1993, Saatman, Bozyczko-Coyne et al.
1996, Hall, Sullivan et al. 2005, Krishnamurthy and Laskowitz 2016). High
intracellular concentration of calcium also contributes to mitochondrial
dysfunction as the organelle becomes overwhelmed attempting to clear cytosolic
calcium, which ultimately leads to increases in reactive oxygen species (ROS),
loss of ATP production, and the commencement of apoptosis (Sullivan,
Thompson et al. 1999, Singh, Sullivan et al. 2006, Chen, Yang et al. 2007). The
occurrence of a multitude of detrimental events overwhelms the cell inducing cell
death which leads to a wave of excess calcium and neurotransmitters, further
propagating cell death through excitotoxicity in surrounding cells (Conti,
Raghupathi et al. 1998, Pleasant, Carlson et al. 2011). Additionally, shearing of
axons and subsequent degeneration and demyelination interrupt signal
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transduction following injury (Meaney, Margulies et al. 2001, Povlishock and Katz
2005, Mac Donald, Dikranian et al. 2007).
Traumatic Axonal Injury
Traumatic axonal injury (TAI) is a common feature of diffuse TBI,
generally resulting from high-velocity rotational forces that result in stretching and
shearing of axons (Hill, Coleman et al. 2016). The majority of axonal damage is
not due to shearing at the time of primary injury	
  (Buki and Povlishock 2006);

rather, demyelination and atrophy along white matter tracts progresses for

decades in TBI patients (Johnson, Stewart et al. 2013, Green, Colella et al.
2014). Axonal pathology develops over the course of days following injury. Within
seconds of stretch injury, the axons become misaligned and take on a wavy
structure due to temporary loss of elasticity (Smith, Wolf et al. 1999). Although
axonal structure recovers, axonal swellings become visible within hours of injury.
Over the course of days to weeks, accumulation disruption of cytoskeletal
elements and cellular transport exacerbates axonal pathology leading to
secondary axotomy, pathologically denoted by the presence of a bulb formation
at the axon terminal (Smith 2000). Traditionally it was believed that all these
damaged axons would disconnect and undergo Wallerian degeneration,
characterized by the degeneration of axon segment distal to the site of
transection (Smith 2000). However, it is now recognized that many of these
damaged axons will not disconnect and dieback, but instead will undergo axonal
repair	
  (Buki and Povlishock 2006).
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Axonal damage is a progressive secondary cascade that manifests as a
interruption of protein transport and breakdown of cytoskeletal elements (Hill,
Coleman et al. 2016). Indeed, labeling of transported proteins, such as amyloid
precursor protein (APP), can be observed localized in axonal swellings within
hours of traumatic injury (Roberts, Gentleman et al. 1991, Roberts, Gentleman et
al. 1994, Smith 2000). It has been proposed that disruption of protein transport is
caused by proteolysis and compaction of the axonal cytoskeleton, which is
primarily composed of neurofilament proteins (Hall and Lee 1995, Povlishock,
Marmarou et al. 1997). In addition to proteolysis, dephosphorylation of
neurofilament proteins may also contribute to compaction of the axonal structure
(Okonkwo, Pettus et al. 1998).
Blood Brain Barrier Breakdown
Disruption of the blood brain barrier (BBB) is a hallmark of severe TBI
(Baldwin, Fugaccia et al. 1996, Price, Wilson et al. 2016). The microvessels of
the BBB are composed of endothelial cells connected by tight junctions; these
endothelial cells interact with the glial cells of the CNS to form a restrictive barrier
between the CNS and the rest of the body (Price, Wilson et al. 2016). Following
primary trauma, vasculature disruption causes a breakdown of the endothelial
tight junctions of the BBB allowing for atypical transport of molecules from the
peripheral blood stream into the brain including clotting agents such as thrombin,
fibrinogen and albumin that decrease blood flow and increase the risk of
ischemia (Chodobski, Zink et al. 2011, Price, Wilson et al. 2016). Increased BBB

	
  

9	
  

permeability also allows for accumulation of plasma proteins and water in the
brain contributing to post-traumatic edema (Greve and Zink 2009, Chodobski,
Zink et al. 2011). Lastly, disruption of the BBB allows for immune cells from the
periphery, such as macrophages and neutrophils, to enter the brain through the
damaged vasculature. Upon infiltration, these cells become active and secrete
cytokines such as TNF-α and IL-1β, which activate resident glial cells initiating a
neuroinflammatory response (Ziebell and Morganti-Kossmann 2010, Chodobski,
Zink et al. 2011, Kumar and Loane 2012).
Glial Activation and Inflammation
Resident astrocytes are important for maintaining homeostasis by aiding
in support of the BBB, secretion and absorption of neurotransmitters, and
maintenance of extracellular ion concentrations (Kolb 2008). Following trauma,
astrocytes become activated; this process of astrocytosis is characterized by
cellular proliferation and hypertrophy (increased expression of glial fibrillary acidic
protein (GFAP), elongation of cellular processes, and cytoplasmic enlargement)
(Saatman, Feeko et al. 2006, Bardehle, Kruger et al. 2013, Burda, Bernstein et
al. 2016). Following brain insult, astrocytes form a glial scar that acts as a
protective barrier between damaged tissue and the intact brain (Villapol, Byrnes
et al. 2014) Although the scar compartmentalizes cellular debris and biochemical
byproducts of the damaged tissue, astrocytes in the scar continue to release
cytokines, that promote inflammation, and chondroitin sulfate, a molecule that
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has been shown to inhibit regeneration and repair (Smith, Miller et al. 1986,
Snow, Steindler et al. 1990, McKeon, Schreiber et al. 1991).
Mircoglia are the resident immune cells of the CNS. In their resting, or
inactive, state they survey tissue for biochemical markers of damage and
infection (Harry 2013). Upon detection of TBI-induced damage, microglia become
activated and begin to release cytokines to signal other glia cells to respond to
injury (Chiu, Liao et al. 2016). These cells, along with peripheral macrophages
and neutrophils (introduced following the breakdown of the BBB), recognize
foreign antigens and clear cellular debris (Harry 2013). Microglia have been
demonstrated to switch between two different states of activation: M1 and M2.
M1 activated microglia release pro-inflammatory cytokines, such as TNF-α and
IL-1β, along with ROS, which lead to further cell death (Chiu, Liao et al. 2016). In
an M2 state, however, microglia promote tissue repair and regeneration by
releasing trophic factors such as insulin-like growth factor-1, anti-inflammatory IL10, and the incretin, GLP-1 (Chiu, Liao et al. 2016). The inability of microglia to
switch between these two states is detrimental to brain health. Sustained
elevation of IL-1β and TNF-α impair the switch from the M1 to M2 phase leading
to neuronal dysfunction (Streit, Mrak et al. 2004).
Treatment of TBI
The activation of a diverse array of secondary injuries cascades has made
the treatment of TBI complex. Disappointingly, to date no pharmacological
treatment for TBI has convincingly shown benefit in a multicenter phase III trial
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and made it to market. The rationale for trial failures have been attributed to a
variety of factors including: drugs not reaching their target, not attaining an
adequate intracranial concentration, or missing the appropriate time for
intervention (Beauchamp, Mutlak et al. 2008). Due to the lack of pharmacological
agents, clinically, the symptoms of TBI are mitigated through the use of mannitol
to decrease brain edema and surgical craniectomy to stabilize intracranial
pressure (Muizelaar, Wei et al. 1983, Munch, Horn et al. 2000). However,
increasing focus on the cellular and molecular changes accompanying TBI
continues to provide new therapeutic targets for drug development (Beauchamp,
Mutlak et al. 2008). One area of focus is on agents that are able to enhance the
brain’s endogenous plasticity and regeneration capabilities.
Recovery following TBI: Neurogenesis
Following trauma, the brain initiates endogenous repair mechanisms,
promoting plasticity and regeneration (Scheff, Price et al. 2005, Rola, Mizumatsu
et al. 2006, Xiong, Mahmood et al. 2010). Although glial cells quickly proliferate
in response to injury, the developed brain has less capacity to replenish lost
neurons. Historically, it was believed that all neurons in the brain were derived
during embryonic development and the adult brain was unable to produce new
neurons throughout the life course. However, it is now understood that resident
neural stem cells are able to self-renew their own pool through proliferation and
also have the ability to differentiate into astrocytes, oligodendrocytes, and
neurons through the process of neurogenesis (Gage 2000). New neurons are
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generated in two discrete niches within the adult brain: in the subventricular zone
of the lateral ventricles and the subgranular zone of the hippocampal dentate
gyrus (Gage 2000). Neurogenesis is a dynamic process and rates of proliferation
are responsive to environmental stimuli (Kempermann, Kuhn et al. 1997, van
Praag, Christie et al. 1999, van Praag, Shubert et al. 2005). Indeed, increased
levels of neurogenesis have been observed following various brain insult
including ischemia (Jin, Minami et al. 2001, Osman, Porritt et al. 2011), seizures
(Parent and Lowenstein 2002, Smith, McLean et al. 2005), and TBI (Dash, Mach
et al. 2001). Although neurogenic activation indicates an attempt at self-repair
following injury, the number of neurons generated, and subsequently integrated
into the circuitry, is too few to generate complete functional recovery	
  (Quadrato,
Elnaggar et al. 2014).

A better understanding of the molecular components that drive neuronal
plasticity and recovery following TBI is needed, for treatments that reduce
neurodegeneration while promoting enhanced plasticity may prove to be
efficacious for the treatment of TBI. Although the molecular mechanisms
contributing to the regulation of neurogenesis are poorly understood, it is
suspected that neurotrophins, such as BDNF, NGF and NT-3, and growth factors
such as IGF-1, bFGF and VEGF, play important roles in the regulation of
neurogenesis (Maisonpierre, Belluscio et al. 1990, Aberg, Aberg et al. 2000,
Carro, Trejo et al. 2001, Lee and Son 2009, Mudo, Bonomo et al. 2009). The Ras
superfamily of GTPases regulate cellular responses downstream of growth factor
stimulation (Katz, Amit et al. 2007) and have been implicated in the control of

	
  

13	
  

processes involved in neuronal plasticity (Darcy, Trouche et al. 2014, Mir, Cai et
al. 2017, Mir, Cai et al. 2017), suggesting that they function critically to regulate
recovery following injury.
Ras superfamily
The Ras superfamily of GTPases encompasses a large family of
structurally related hydrolysis enzymes that function to regulate a variety of
cellular processes by acting as molecular switches relaying extracellular stimuli
to the activation of appropriate intracellular responses (Reuther and Der 2000,
Colicelli 2004, Wennerberg, Rossman et al. 2005). The Ras superfamily can be
separated into five subfamilies: Ras (Rat sarcoma), Rho (Ras homolog gene
family), Rab (Ras-related GTP-binding protein), Ran (Ras-related nuclear
protein), and Arf (ADP-ribosylation factor) (Colicelli 2004). Ras family protein
signal transduction cascades commonly activate cell proliferation and survival
responses (Satoh, Nakafuku et al. 1992, Downward 1998, Wennerberg,
Rossman et al. 2005). Rho proteins are associated with the regulation of
cytoskeletal dynamics and cell morphology (Jaffe and Hall 2005, Wennerberg,
Rossman et al. 2005). The Rab family is critical in modulating membrane
trafficking (Stenmark and Olkkonen 2001, Wennerberg, Rossman et al. 2005),
while Arf proteins function in vesicular transport (Wennerberg, Rossman et al.
2005, Gillingham and Munro 2007), and the Ran family in nuclear transport
(Pemberton and Paschal 2005, Wennerberg, Rossman et al. 2005). Although the
functions of many GTPases have been well characterized, there remains a
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subset whose physiological roles have not been defined. The focus of this
dissertation is one such protein of the Ras subfamily, Rin (Ras-like protein in
neurons).
GTPase cycle
Despite the broad array of functions controlled by different small GTPase
families, a majority of the Ras superfamily shares a conserved protein core that
is responsible for nucleotide binding and hydrolysis (Colicelli 2004). This core
region drives a conformational switch between an inactive, GDP-bound, and
active, GTP-bound, structural state. In their GTP-bound structural state Ras
GTPases are capable of associating with, and activating, a diverse array of
cellular effector proteins (Wennerberg, Rossman et al. 2005). It is the capability
of GTPases to function as GTP/GDP driven molecular switches that permits
them to serve as critical regulators of diverse cell signaling cascades (Figure
1.2).
The activation of the small GTPases is dependent on nucleotide
exchange. When GDP is bound, the protein is found in an “inactive”
conformational state, with the G2 effector loop buried within the protein. This
conformational state inhibits the interaction of Ras G-proteins with their
downstream effectors, thereby preventing signaling. The binding affinity for
guanine nucleotides is high, with a Kd value in the 10-11M range; therefore,
spontaneous activation of Ras proteins does not occur under physiological
conditions	
  (Lowy and Willumsen 1993). Furthermore, the intrinsic hydrolysis
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activity of these enzymes is low and, without assistance, inactivation of the GTPbound active state would not occur on a biologically effective time scale (Lowy
and Willumsen 1993). Rather, two families of regulatory factors control rapid
activation and inactivation of the GTPase: guanine nucleotide exchange factors
(GEFs) and GTPase-activating proteins (GAPs) (Figure 1.2). GEF proteins bind
to the small GTPase inducing the release of bound nucleotide (Quilliam,
Khosravi-Far et al. 1995, Bernards and Settleman 2007). Upon GEF-mediated
nucleotide release, the nucleotide free GTPase rapidly binds GTP given its
intracellular concentration is approximately 10-fold higher than GDP. To
overcome the slow rate of intrinsic hydrolysis, binding of GAP proteins stimulate
the enzymes’ intrinsic hydrolysis rate (Bernards and Settleman 2005). Members
of the Rho and Rab family have an additional level of regulation through binding
to guanine nucleotide dissociation inhibitor (GDIs) (Geyer and Wittinghofer 1997)
(Figure 1.2). GDIs bind to GDP-bound enzymes to prevent GEF binding and
membrane targeting, retaining an inactivated state (Geyer and Wittinghofer
1997).
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Figure 1.2. The GTPase cycle. Ras family protein cycle between an inactive
GDP-bound state and an active GTP-bound conformation. Guanine nucleotide
exchange factors (GEF) trigger the release of GDP, which is promptly replaced
by GTP. Binding of GTP elicits a conformational change allowing for binding to
downstream effector proteins. GTPase-activating proteins bind to Ras proteins to
increase their intrinsic GTP hydrolysis, releasing inorganic phosphate and
returning Ras to its inactive state. Rab and Rho proteins interact with guanine
nucleotide dissociation inhibitors (GDIs) to prevent GEF binding and maintain an
inactive conformation.

	
  

17	
  

Ras Biochemical Characteristics and Structure
The Ras superfamily shares five highly conserved core regions, or G box
sequences, that confer their biochemical activity of guanine nucleotide binding
and hydrolysis (Figure 1.3) (Barbacid 1987, Lowy and Willumsen 1993, Colicelli
2004). The G1 sequence is necessary for binding to the α and β-phosphates of
purine nucleotides and is also referred to as the P-loop or Walker A motif
(Colicelli 2004). The G3 domain binds the γ-phosphate group of GTP and the
nucleotide associated magnesium ion (Lowy and Willumsen 1993). G4 and G5
regions are responsible for nucleotide specificity, conferring selective GTP
binding instead of ATP, as they specifically bind the guanine ring (Colicelli 2004).
Of all the G box domains, G2 is the least conserved among Ras family members.
The G2 domain is also referred to as the “effector domain” because it serves as
the primary site of interaction for downstream effectors following activation by
GTP binding (Colicelli 2004). Therefore, the diversity of the G2 sequence allows
for small GTPases to recognize distinct collections of effector proteins, which
regulate diverse physiological functions. Furthermore, the G2 and G3 domains
undergo nucleotide-dependent conformational alterations (Cherfils and Zeghouf
2011). When in contact with the γ-phosphate of GTP, the two loops are exposed
to the surface of the GTPase core allowing for recruitment of effectors and the
initiation of downstream signaling (Cherfils and Zeghouf 2011). Upon GTP
hydrolysis, the loops change position and are buried within the protein and
effector recruitment is terminated, thus ceasing downstream signaling cascades
(Cherfils and Zeghouf 2011).
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A majority of Ras-related small G-proteins rely on membrane localization
for their biological activity, although they do not encode transmembrane spanning
domains. Instead localization is most often achieved by post-translational
prenylation, palmitoylation, and/or myristoylation. The carboxy terminus of Ras
proteins contains two signal sequences that promote their association with lipid
membranes (Reuther and Der 2000). The C-terminal CAAX motif (where the C is
cysteine, the A is an aliphatic amino acid and the X is variable) is the recognition
site for protein prenyltransferases. Following prenylation, the AAX tripeptide is
proteolytically cleaved and the C-terminal cysteine is methylated leading to a
more hydrophobic protein that displays greater membrane association (Lowy and
Willumsen 1993). Specific targeting often requires additional post-translational
modifications. For H-Ras and N-Ras there are additional cysteine residues
upstream of the prenylation signal that becomes reversibly palmitylated to further
increase membrane affinity (Lowy and Willumsen 1993). Arf family proteins lack
a C-terminal prenylation site and are instead myristoylated at the N-terminus to
promote membrane association (Casey 1994). Lastly, there are several members
of the Ras family that lack lipid modification motifs, specifically the Rad/Gem/Kir
(RGK) and Rit subfamily of GTPases (Colicelli 2004). Instead, these subfamilies
contain extended poly-basic C-terminal regions which promote membrane
association through charged interactions with phosphatidylinositol 3,4,5triphosphate [PI(3,4,5)P3] and phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2]
on the plasma membrane (Heo, Inoue et al. 2006). Interestingly, these proteins
lacking canonical membrane targeting sequences have also been demonstrated
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to migrate in and out of the nucleus (Heo, Inoue et al. 2006). However, it is
currently unclear how C-terminal membrane targeting and nuclear localization
impact the biological activity of this set of enzymes.
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Figure 1.3. Alignment of the Rit subfamily of small GTPases. Rin and RIt
define the Rit subfamily of small GTPases. Consensus G box motifs are
highlighted in yellow. NCBI reference sequences are as follows: dRic
NM_057863, hRin NM_002930.3, hRit NM_001256821.1, hHRas NM_005343.3
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Rit subfamily of GTPases
The Rit subfamily of Ras-related GTPases is comprised of Rit (Ras-like in
tissues), Rin (Ras-like in neurons) in vertebrates and the Drosophlia ortholog, Ric
(Ras-related protein which interacted with calmodulin) (Lee, Della et al. 1996,
Wes, Yu et al. 1996, Shao, Kadono-Okuda et al. 1999). Although Rit and Rin
share 64% of their amino acid sequence identity, they display variability in their
patterns of developmental and tissue expression	
  (Lee, Della et al. 1996). Rit is

expressed ubiquitously and throughout development, while Rin is expressed

solely in central nervous system neurons and its expression suppressed until
embryonic day 13 (Lee, Della et al. 1996, Shao, Kadono-Okuda et al. 1999,
Cahoy, Emery et al. 2008, Sharma, Schmitt et al. 2015). Both Rit and Rin have
unique biochemical and structural properties that distinguish them from other
members of the Ras subfamily (Shi, Cai et al. 2013).
Biochemical Characterization of the Rit subfamily
The Rit subfamily members act as canonical GTPases having high
preferential binding affinity for guanine nucleotides and low intrinsic hydrolysis
activity (Lee, Della et al. 1996, Shao, Kadono-Okuda et al. 1999). Despite their
functional similarity, the Rit subfamily is structurally unique. Although the G box
domains of the Rit subfamily are highly conserved, both Rit and Rin have
extended N- and C-termini accounting for the proteins’ higher molecular weights
of approximately 25kDa, compared to roughly 21kDa for other Ras family
members (Figure 1.3). Membrane localization is achieved in both Rit and Rin
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through a stretch of polybasic amino acids at the C-terminus (Shao, KadonoOkuda et al. 1999, Heo, Inoue et al. 2006).
Rit and Rin also share a unique G2 effector domain (HDPTIEDAY) that is
distinctive of the Rit subfamily and unique among other GTPases, although most
similar to the Ras subfamily with only two amino acid substitutions (YDTIEDSY)
(Figure 1.3). To test the hypothesis that these amino acids substitutions would
lead to differences in effector binding between the Rit and Ras family, a yeast–
two hybrid experiment was performed using either constitutively active or
dominant negative Rit and Rin as bait and known Ras effectors as prey (Shao,
Kadono-Okuda et al. 1999). In these experiments H-Ras was able to interact with
the Ras binding domain of Raf1 (Raf1-RBD), the Ras interaction domain of
RalGDS (RalGDS-RID), the Ras interaction domain of Rlf (Rlf-RID), AF6, RIN1,
and the p110 catalytic subunit of PIK3	
  (Shao, Kadono-Okuda et al. 1999). It was
demonstrated that Rit and Rin were able to interact with only a subset of the

effectors tested (Raf1-RBD, RalGDS-RID, Rlf-RID and AF6)	
  (Shao, Kadono-

Okuda et al. 1999). The Drosophila ortholog, Ric, contains an intermediate G2
effector domain containing only one amino acid substitution (HDTIEDSY);
however, studies have not been conducted to determine how this may impact
effector binding.
Initial biochemical characterization found that both Rit and Rin displayed
guanine nucleotide dissociation rates of 5 to 10-times higher than Ras GTPases
(Shao, Kadono-Okuda et al. 1999). Given the high concentration of intracellular
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GTP compared to GDP, this in vitro study suggested a high basal rate of
activation for these proteins. However, subsequent affinity isolation of activated
(GTP-bound) Rit and Rin from cell culture studies demonstrated only modest
levels of GTP bound protein in unstimulated cells, measured through GTPselective pull-down assays (Shao and Andres 2000, Hoshino and Nakamura
2002). This suggests that the high basal rates of activation seen in vitro may
result from the C-terminal deletion necessary for bacterial expression.
Furthermore, a series of oncogenic Rit mutations that drive transformation have
been discovered (Berger, Imielinski et al. 2014, Xu, Sun et al. 2015, Cave, Caye
et al. 2016), further supporting the hypothesis that Rit subfamily activity is
controlled through the conical GTP/GDP cycle.
Activation of the Rit subfamily has been found to be stimuli dependent.
Previous work has indicated that Rit becomes activated following exposure to
epidermal growth factor (EGF), nerve growth factor (NGF), neurotropic peptide
pituitary adenylate cyclase activated polypeptide 38 (PACAP38), and various cell
stressors (TNF-α, DNA damage and oxidative stress) (Spencer, Shao et al.
2002, Shi and Andres 2005, Shi, Rehmann et al. 2006, Lein, Guo et al. 2007,
Shi, Jin et al. 2010, Shi, Jin et al. 2011). Using a similar experimental approach,
Rin has also been shown to be activated following NGF, EGF, PACAP38, and
12-myristate stimulation (Spencer, Shao et al. 2002, Hoshino and Nakamura
2003, Shi, Han et al. 2005).
Function of the Rit subfamily in TBI
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A previous graduate student in the laboratory, Dr. Weikang Cai,
demonstrated that Rit mediates an evolutionarily conserved p38 MAPKdependent pro-survival pathway in response to reactive oxygen species (ROS)
(Cai, Rudolph et al. 2011, Shi, Jin et al. 2011). Elevated concentrations of ROS
is thought to be one of the key mediators of neuronal loss in the setting of TBI
(Zink, Szmydynger-Chodobska et al. 2010), leading him to speculate that Rit may
function in oxidative stress resistance within neurons. Through his studies, it was
found that Rit deficiency sensitized immature neurons and delayed neurogenic
recovery within the dentate gyrus of the hippocampus to cell death following TBI,
suggesting that Rit functions to promote immature neuronal survival and traumamediated hippocampal neurogenesis (Cai, Carlson et al. 2012).
To date, there is no literature accessing the role of Rin in TBI. However,
because of the overlap in biochemical properties and activating stimuli between
Rin and Rit, along with its neuron specific pattern of expression, we hypothesize
that Rin signaling will play an important role following brain injury. Indeed, in vitro
studies have demonstrated potential roles for Rin upstream of signaling
pathways activated following trauma. These pathways and their regulation by Rin
are described below.
Rin-mediated Signal Transduction Pathways and their Implications in TBI
The mitogen activated protein kinase (MAPK) signaling cascade is a wellcharacterized effector pathway known to be regulated by many Ras subfamily
proteins. Generically, the pathway consists of a three tiered protein kinase
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cascade in which each subsequent kinase is subject to activation by the previous
kinase. The most upstream level of the pathway is composed of the MAP kinase
kinase kinase (MAPKKK) that activates the MAP kinase kinase (MAPKK), which
in turn activates the MAP kinase (MAPK) (Katz, Amit et al. 2007) (Figure 1.4).
This three-tiered signaling system is shared by three major pathways named
according to their MAPK protein: extracellular signal-related kinases (ERK1/2),
p38 MAPK, and Jun amino-terminal kinases (JNK1/2/3) (Robinson and Cobb
1997, Katz, Amit et al. 2007). The ERK1/2 pathway is regulated by growth factor
stimulation (Katz, Amit et al. 2007). Although p38 and JNK1/2/3 can be activated
by growth factors, however, are more often induced by stimuli such as osmotic
stress, UV irradiation, oxidative stress, hypoxia and cytokines (Katz, Amit et al.
2007, Raman, Chen et al. 2007). Rin has been demonstrated to act upstream
and regulate the activity of both ERK and p38 pathways (described below).
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Figure 1.4. Receptor tyrosine kinase (RTK)-mediated Ras MAPK Cascade.
Extracellular ligand binding causes the RTK to dimerize triggering
autophosphorylation of tyrosine residues on the cytoplasmic tail of the RTK.
Phosphorylation of specific receptor tyrosine residues allows binding of adaptor
proteins, such as Shc and Grb2, through their SH2 domains. These adaptors
recruit GEFs such as Sos1, which can activate Ras when brought into proximity
of the plasma membrane where Ras is localized. Following GTP binding, Ras
activates downstream MAPKKK/MAPKK/MAPK signaling. These signaling
proteins are often held in close proximity by scaffolding proteins to allow more
efficient signaling. Following phosphorylation, the MAPK protein is able to
dimerize and translocate to the nucleus where it activates transcription factors to
initiate gene transcription to promote biological processes including cell survival,
differentiation, and growth.
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Raf/MEK/ERK MAPK Cascade
ERK is rapidly activated (within 10 minutes) in experimental models of
contusive brain injury	
  (Mori, Wang et al. 2002, Hu, Liu et al. 2004). Activated ERK

has been primarily observed in neurons, initially localizing to the axons and at

later time points translocating to the cell body (Dash, Mach et al. 2002). Although
activation has been demonstrated, the physiological outcome of ERK activation
is not well characterized. It has been demonstrated that inhibition of ERK
signaling prior to injury leads to worsened behavioral and cognitive outcomes
following head injury, suggesting that ERK activation is beneficial (Dash, Mach et
al. 2002). However, a separate contusive TBI study found that mice treated with
an ERK inhibitor displayed no change in motor function; however, they did have
a significantly reduced lesion volume compared to vehicle treated controls,
suggesting that ERK plays deleterious roles in TBI (Mori, Wang et al. 2002). In a
diffuse head injury model, treatment with S-trans-farnesylthiosalicylic acid (FTS),
which disrupts prenylated protein membrane association, diminished ERK
activation, and led to decreased neurological defects, once again suggesting
diminished ERK activation to be beneficial (Shohami, Yatsiv et al. 2003).
Although functional results have varied in these studies, possibly due to
differences in the type or severity of injury or differences in cells or regions
affected, it has been consistently demonstrated that ERK is activated by
mechanical strain (Neary 2005).
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Initial yeast-two hybrid analysis indicated interaction between Rin and the
Ras binding domain of Raf1 suggesting that Rin may function to regulate ERK
signaling (Shao, Kadono-Okuda et al. 1999). Subsequent studies demonstrated
that although Rin could bind both Raf1 and B-Raf in a GTP dependent manner,
Rin preferentially bound B-Raf (Shi, Han et al. 2005). In agreement with these
binding studies, Rin was found to only activate signaling downstream of B-Raf.
Importantly, RNAi-mediated Rin silencing was demonstrated to inhibit NGFinduced B-Raf activation in PC6 cells (Shi, Han et al. 2005). Furthermore,
expression of constitutively active Rin led to ERK activation, and pretreatment
with the MEK inhibitor, PD98059, blocked Rin-mediated ERK activation
(Spencer, Shao et al. 2002, Shi, Han et al. 2005). Together these data implicate
Rin as an upstream regulator of the B-Raf-MEK1-ERK cascade.
p38 MAPK Cascade
The p38 MAPK cascade has been implicated in a multitude of processes
within the CNS. Activation of the p38 MAPK cascade has been associated with
neuronal death caused by numerous neurotoxic reagents including excitotoxicity
(Cao, Semenova et al. 2004, Semenova, Maki-Hokkonen et al. 2007, ChaparroHuerta, Flores-Soto et al. 2008), nerve injury (Wittmack, Rush et al. 2005), and
ischemia (Wang, Xu et al. 2002, Guo and Bhat 2007). Furthermore, rapid
activation of p38 has been observed following contusive brain injury (Mori, Wang
et al. 2002). Expression of p38 is ubiquitous and the outcomes of its activation
vary based on cell type. In microglia, p38α has been demonstrated to be critical
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for the production of IL-1β and TNFα (Bachstetter, Xing et al. 2011) and following
TBI microglial p38α regulates the acute phase cytokine response and microglial
activation (Bachstetter, Rowe et al. 2013). Therefore, the ability of a protein or
molecule to regulate p38 function could have broad therapeutic potential.
Studies conducted in cell culture models indicate that Rin plays a role in
regulating p38 signaling cascades. RNAi-mediated silencing of Rin blunts p38
activation downstream of NGF stimulation demonstrating that Rin activation is
critical in the p38 cascade (Shi, Han et al. 2005). Interestingly, silencing of Rin
had no effect on the ability of other stimuli, including EGF, PMA, and calcium
ionophore, to activate downstream p38 signaling (Shi, Han et al. 2005)
suggesting signaling specificity downstream NGF. It was also shown that Rin coexpression with B-Raf was able to robustly stimulate p38 activation
demonstrating a role for B-Raf in Rin-mediated p38 signaling (Shi, Han et al.
2005). Current data suggests that Rin may function more prominently in p38
signaling than upstream of ERK cascades (Shi, Han et al. 2005).
Regulation of Rho family GTPases
RhoA, Cdc42, and Rac are members of the Rho subfamily of GTPases
(Colicelli 2004). These proteins act as GDP/GTP-dependent binary switches, and
have been shown to regulate many aspects of intracellular actin dynamics,
controlling critical functions including cell migration, polarity, and mitosis (Jaffe
and Hall 2005). In the CNS, the Rho subfamily of GTPases mediates neurite
outgrowth, growth cone development, and dendritic arborization	
  (Stankiewicz and
	
  

31	
  

Linseman 2014). More recently the Rho family has been implicated in roles of
neuronal survival and neurodegeneration (Stankiewicz and Linseman 2014).
Indeed, expression of activated RhoA induces neuronal cell death (Semenova,
Maki-Hokkonen et al. 2007) and Rac1 is associated with neuronal survival
(Stankiewicz and Linseman 2014). Following TBI, Rac1 and RhoA proteins are
activated and relocate to the membrane (Sabirzhanova, Liu et al. 2013). The
physiological outcomes of Rho activation and relocation following TBI are
unclear. However, effects could range from regeneration to cell death.
Literature indicates that Rin interacts with proteins in the Rho subfamily
and has the ability to modulate cytoskeletal dynamics. It was demonstrated that
Rin forms complexes with Par6-Rac/Cdc42 in a GTP-dependent manner
(Hoshino, Yoshimori et al. 2005) and Rin expression promotes Rac/Cdc42 and
RhoA activation (Hoshino and Nakamura 2003) suggesting Rin expression may
modulate Rho family physiological functions.
Rin-mediated Neurite Outgrowth
The most commonly studied physiological outcome of Rin activation is
neuritogenesis, or the ability of a neuron to form cytoskeletal projections from the
cell body. Although Rin activation induced neurite outgrowth (Hoshino and
Nakamura 2003, Shi, Han et al. 2005), it should be noted that its effect is not
robust and has been demonstrated in immortalized cell lines, not within cultured
neurons. However, expression of constitutively active Rin induced neuritogenesis
in PC6 cells; furthermore, additional expression of B-Raf enhanced the
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percentage of neurite bearing cells, the number of neuritis per cell and their
branching (Shi, Han et al. 2005). It has been shown that p38 or ERK inhibition
reduced neurite outgrowth following expression of constitutively active Rin (Shi,
Han et al. 2005) (Figure 1.5). These data demonstrate a role for Rin in neuronal
differentiation downstream of p38 and ERK. Rin-dependent neurite outgrowth
has also been demonstrated downstream of Rho subfamily activation. Indeed
Rin-dependent differentiation of PC12 cells downstream of NGF was diminished
by the expression of dominant negative Rac/Cdc42, suggesting a role for Rin in
calcium-mediated cytoskeletal reorganization upstream of the Rho subfamily of
GTPases (Hoshino and Nakamura 2003). Finally, Rin-dependent neurite
outgrowth has been demonstrated through interaction with calmodulin (CaM).
CaM is a ubiquitous expressed calcium sensing protein for a variety of cellular
enzymes; it is able to respond to increases in intracellular calcium concentration
and activate a variety of cellular processes including cytoskeletal organization
(Rhoads and Friedberg 1997). Rin binds calmodulin (CaM) in a calciumdependent manner through its C-terminus (193-217 aa), suggesting that Rin may
mediate calcium/CaM-modulated signaling pathways (Lee, Della et al. 1996).
Indeed, it was found that Rin is able to form a complex with the actin binding
protein IQGAP1 and CaM and this interaction was demonstrated to contribute to
neurite outgrowth (Hoshino and Nakamura 2003) (Figure 1.5).
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Figure 1.5 Rin-dependent signaling in neurite outgrowth. Rin signaling has
been implicated upstream of ERK, p38, and Cdc42/Rac1 and in each of these
cases shown to induce neurite outgrowth in PC6/12 cells.
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Rationale for Investigating the Physiological Function of Rin
Rin activation has been demonstrated downstream of a variety of stimuli;
however, the physiological function of Rin in the CNS remains poorly
characterized. Rin signaling upstream of ERK, p38, and Cdc42/Rac has been
shown to contribute to neurite outgrowth (Hoshino and Nakamura 2003, Shi, Han
et al. 2005), suggesting a potential role for Rin in plasticity following brain injury.
Regardless, these studies were performed in cultured cell models that do not
accurately reflect the physiological conditions of neurons. This is particularly
problematic considering the expression of Rin is limited to neuronal populations
(Lee, Della et al. 1996, Spencer, Shao et al. 2002, Cahoy, Emery et al. 2008,
Sharma, Schmitt et al. 2015), raising the question of whether or not these
cultured cells express the necessary effector and regulatory proteins required for
authentic replication of the function of endogenous Rin signaling. In order to
study the function of Rin in an appropriate system, we generated a Rin null
mouse line through genetic deletion of RIT2, and with this line we characterized
the physiological roles of Rin using a number of experimental trauma models. In
Chapter Three, we implemented a contusive brain injury model (CCI) to
characterize the effects of Rin loss on trauma-induced neurogenesis and cell
death. These studies indicate that Rin, unlike Rit, does not function in traumainduced neurogenesis or the survival of immature neurons within the dentate
gyrus of the hippocampus. Rather, this set of experiments demonstrates a
neuroprotective effect of Rin loss, as its genetic deletion increases neuronal
survival in the hippocampal dentate gyrus and CA-3 subregion. Furthermore, we
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were able to correlate neuronal protection with cognitive behavioral sparing. In
Chapter 4, we examined the role of Rin in trauma-induced axonal degeneration
following optic nerve stretch, an experimental model of white matter tract injury.
These studies indicate that the loss of Rin protects cells from axonal
degeneration and limits injury-induced inflammation. In Chapter 5, we employed
a diffuse closed head injury (CHI) model of TBI to analyze the role of Rin in
trauma-induced neuroinflammation. In this model, we show that Rin loss blunts
pro-inflammatory IL-1β cytokine production acutely following injury while
elevating anti-inflammatory IL-10 production in the cortex. Although we did not
observe any observable alterations in microglia or astrocyte activation, there was
an appreciable reduction in axonal degeneration in Rin null animals following
CHI. These data suggest that the differences observed in cytokine profiles may
be a result of reduced neuronal cytokine production. Together, the studies in this
dissertation demonstrate broad neuroprotective effects of Rin loss in cell death,
axonal degeneration and inflammation and could provide insight into treatment of
brain trauma and neurodegenerative disorders.
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CHAPTER TWO

Materials and Methods

Reagents
Chapter 3
Reagents: 5-Bromo-2-deoxyuridine (BrdU) (Thermo Fisher Scientific); formalin
(Sigma #HT501128); FluoroJade C (FJC); ABC kit (Vector #PK-6100); DAB
Peroxidase substrate kit (Vector SK-4100)
Antibodies: rabbit antiNeuN (Millipore #MABN140); rabbit antiKi67 (Abcam
#ab15580), rat BrdU (Abcam #ab6326), rabbit anti-Dcx (Abcam #ab18723);
rabbit anti-GFAP (Dako #Z0334); goat anti-rabbit IgG TRITC (Jackson
ImmnuoResearch #111-605-144); goat anti-rat IgG Cy3 (Jackson
ImmnuoResearch #112-605-167); goat anti-rabbit IgG FITC (Jackson
ImmnuoResearch #111-545-144); mouse anti-Rit (R0003U) and mouse-anti-Rit2
clone 27G2 were generated in collaboration with Gamma-1 (Lexington, KY).
Chapter 4
Reagents: ABC kit (Vector #PK-6100); DAB Peroxidase substrate kit (Vector SK4100); formalin (Sigma #HT501128)
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Antibodies: mouse anti-Neurofilament H Nonphosphorylated (SMI32)
(Calbiochem #NE1023); rat anti-CD68 (BioRad # MCA 1957), biotin donkey antirat IgG (Jackson ImmunoResearch #712-065-150); biotin donkey anti-mouse IgG
(Jackson ImmunoResearch #715-065-150)
Chapter 5
Reagents: Methyl green, zinc chloride salt (VWR); DAB (Sigma); Halt Protease &
Phosphatase Cocktail (Pierce #78442); PMSF (Sigma P7626); ABC kit (Vector
#PK-6100); Custom mouse cytokine kit (MSD #K152A0H-1)
Antibodies: rabbit anti-GFAP (Dako #Z0334); rat anti-CD45 (Thermo #MA181247); rabbit anti-βAPP (Invitrogen #51-2700); biotin goat anti- rabbit IgG
(Jackson ImmunoResearch #111-035-144); biotin goat anti-rat IgG (Vector #BA9401)
Animals
Rin-/- mice were purchased from Texas Institute for Genomic Medicine
(mouse accession: NM_009065) (College Station, TX). RinWT allele was
genotyped with primers 5’-GACACTGCATGAGACTGA ACC - 3’ and 5’CTATAACCTGTGAGTCAACGGAAA G - 3’ corresponding to the intronic region
between exons 3 and 4 resulting in a band of approximately 750 nucleotides. Rin/-

allele was genotyped with primers 5’ – AAATGGCGTTACTTAAGCTAGCTTGC

- 3’ and 5’ - CTATAACCTGTGAGTCAACGGAAAG - 3’ corresponding to the
intronic region between exon 3 and 4 and the LTR sequence on the gene trap
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insertion resulting in a band of approximately 650 nucleotides. Animals were
handled in accordance with standard use protocols and animal welfare
regulations of the Institutional Animal Care and Use Committee (IACUC) of the
University of Kentucky and the NIH Guide for the Care and Use of Laboratory
Animals.
Traumatic Injury Models
For all experiments herein, animals were randomly assigned into either
injured or sham groups. All cell counts and analyses was conducted by
experimenters blinded to both the genotype and experimental treatment of study
animals.
Controlled Cortical Impact (CCI)
Surgeries were carried out in the laboratory of Kathryn Saatman by Shaun
Carlson, Erica Littlejohn, and Travis Stewart and were performed as previously
described (Pleasant, Carlson et al. 2011). All CCI injuries were performed on
male mice to control for head size and limit injury severity variation. Briefly,
isoflurane anesthetized twelve-week-old male mice received a craniotomy over
the left hemisphere and were subjected to a unilateral controlled cortical impact
(CCI) injury at a 1.0 mm impact depth and a nominal velocity of 3.5 m/s using a
CCI impactor device (TBI-0310 Impactor; Precision Systems and
Instrumentation). Sham animals underwent identical surgical procedures, but
received no impact to the cortex.
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Mono-ocular Nerve Stretch Injury (MONS)
Surgeries were performed in the laboratory of Kathryn Saatman by Binoy
Joseph as previously described (Saatman, Abai et al. 2003). Briefly, 6-8-monthold mice were anesthetized with a 65 mg/kg intraperitoneal injection of sodium
pentobarbital and maintained on a heading pad throughout the surgery. The
conjunctiva and extraocular muscles were cut around the circumference of the
eye and a flexible sling with a longitudinal midline slit was placed under the eye
positioning the optic nerve in the slit. The sling was connected to a force
transducer (ELF T500-1; Entran, Fairfield, NJ, USA) mounted in a series with a
solenoid (Lucas-Ledex, Vandalia, OH, USA) and in parallel with a displacement
transducer (Trans-Tek Inc., Ellington, CT, USA). Elongation of the optic nerve by
2.0 mm (extending the nerve by approximately 20%) was obtained by
programming of the solenoid and measured by the force transducer.
Optic Nerve Transection
Operational procedures were modified from an optic crush protocol
(Templeton and Geisert 2012). Six-to-eight-month-old male and female mice
were anesthetized via an intraperitoneal injection of 65 mg/kg sodium
pentobarbital and placed on a heating pad for surgery. Once deeply
anesthetized, the eyelashes and whiskers surrounding the right eye were
trimmed and the right cornea was treated with bupivacaine to further numb the
surgical area. Under a dissecting scope, an incision was made into the
conjunctiva along the globe of the eye being careful to not cut the surrounding
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musculature. The edge of the conjunctiva was held with forceps and rotated
nasally bringing the optic nerve into view. Spring scissors were used to cut
through the optic nerve 1-3 mm from the base of the eye. The incision was
washed with 1.0 ml of sterile saline and the eye lids sutured closed. Mice were
maintained on a heating pad until they were fully awake, then monitored daily
until euthanasia. The contralateral eye underwent no surgical procedure and was
used as the experimental control for transection studies.
Closed Head Injury (CHI)
Surgeries were carried out by Adam Bachstetter and were performed as
previously described (Bachstetter, Webster et al. 2015). Briefly, 5-6-month-old
male and female mice were anesthetized using isoflurane and received a sagittal
midline incision of the scalp and received a single midline cortical impact to the
skull cap using a 5.0 mm diameter steel tip impounder (Leica Biosystems,
Wetzler, Germany) at a controlled velocity of 5.0 ± 0.2 m/s with a dwell time of
100 ms at a programmed impact depth of 1 mm. Sham animals underwent
identical surgical procedures, but received no impact to the skull. Animals that
displayed hemorrhaging or skull fracture/deformation were excluded from further
analysis.
Rin Immunoblotting
Whole brain lysates were prepared from wild-type and Rin-/- animals using
kinase lysis buffer [20 mM Hepes (pH 7.4), 150 mM NaCl, 50 mM KF, 50 mM βglycerolphosphate, 2 mM EGTA (pH8.0), 1 mM Na3VO4, 1% Triton X-100, 10%
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glycerol, and 1× protease inhibitor cocktail set I (Calbiochem)]. Total protein
concentration of the lysate was determined using a Bradford assay. Equal
amounts of wild-type and Rin-/- lysates were ran on a SDS-PAGE gels and
protein level was determined by immunoblotting with the appropriate antibodies.
BrdU Administration
To assess immature neuronal survival, BrdU (50mg/kg in 0.9% saline)
was intraperitoneally injected daily for one week as previously described (Cai,
Carlson et al. 2012). Following the final injection, mice were housed for 2 days
prior to injury to allow a subset of the labeled pool adequate time to differentiation
to an immature neuronal lineage.
Tissue Preparation
For CCI and MONS, animals were deeply anesthetized with FatalPlus and
transcardially perfused with a heparin saline solution (heparin sodium 1:1000, RX
grade, APP Pharmaceuticals in 0.9% NaCl) followed by 10% buffered formalin
(Sigma). Tissue was post-fixed in the skull for 24 hr in 10% buffered formalin.
Following post-fixation, the brains and optic nerves were dissected from the skull
and cyroprotected using a 30% sucrose in 1X TBS until tissue sunk. Brains were
snap frozen in isopentane (≤ -20oC) for 2 min and cut in a coronal plane at a 40
µm thickness using a freezing sliding microtome (Dolby-Jamison). Optic nerves
were frozen in OCT and cut in 10 µm sections using a freezing sliding microtome
(Dolby-Jamison). Following CHI, animals were anesthetized with FatalPlus and
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transcardially perfused with heparin saline solution (heparin sodium 1:1000, RX
grade, APP Pharmaceuticals in 0.9% NaCl) and the brain separated into two
hemispheres, one for sectioning and one for protein extraction. The left
hemisphere was tissue was post-fixed in 4% PFA for 24 hr before being
transferred to 30% sucrose and processed in the same manner as the CCI
brains.
Cresyl Violet Brain Staining
Serial sections at 400 µm intervals were mounted onto gelatin-coated
slides and dried overnight at RT. The following day slides were immersed in
ddH20 for 2 min then dehydrated through an ethanol gradient of 70%, 80%, 95%,
and 100% for 2 min at each concentration followed by rehydrated at 100%, 95%,
80%, and 70%. Slide were then incubated in 0.5% cresyl violet for 2.5 min. Slides
were once again dehydrated through a fresh EtOH gradient and immersed in
xylene for 15 min prior to applying a coverslip with permount.
Injury Volume Quantification
To determine the percent of cortex damage following CCI injury, cresyl
violet (Nissl) stained serial brain sections, 400 µm apart, were visualized on an
Olympus BX-51 light microscope equipped with a CCD camera. Neocortical
tissue from bregma level 0 to -3.5 mm was analyzed via live imaging using
Bioquant software (version 8.40.20, Bioquant Life Science). Regions containing
neurons within the ipsilateral and contralateral neocortices were outlined
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separately at 10X magnification verified through examination of cell body
morphology at 2X magnification. Areas of the cortex that contained condensed
nuclei were excluded from the “intact” tissue quantification. Contusion area was
calculated as the difference between spared contralateral and ipsilateral
neocortical areas. The contusion volume was determined using Cavalieri’s
principal, integrating over the inter-section distance as previously described
(Pleasant, Carlson et al. 2011). Data are represented as the percent contralateral
neocortical volume.
Fluoro-Jade C staining
Serial brain sections at 400 µm intervals were mounted on gelatin coated
slides and dried at 40-45o C for 15 min followed by overnight drying at RT. The
following day, sections were washed in 80% (v/v) ethanol with 1% (w/v) NaOH,
70% ethanol and dH2O followed by 10 min incubation in 0.06% (w/v) potassium
permanganate. The sections were then washed in dH2O 5 times before
incubation in 0.0001% Fluoro-Jade C solution (resuspended in 0.1% acetic acid)
followed by 5 more washes in dH2O. Sections were counterstained with Hoechst,
dried, cleared with xylene, and coverslipped with Cytoseal. FJC+ cells in three
sections (pre-epicenter, epicenter, and post-epicenter) of the hippocampus for
each animal were counted on a Nikon Eclipse E600 fluorescence microscope
using a 40X objective. Data are expressed as the sum of FJC+ cells over three
sections. Representative images were taken on a Nikon CKX31 A1 confocal
microscope (20X objective).
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Immunofluorescence
Free floating brain sections at 400µm intervals were washed in 1X TBS
prior to antigen retrieval using 2N HCl for 1 hr at RT and neutralized with 0.1M
borate buffer at RT for 10 min. Following washing with 1X TBS, sections were
blocked in blocking buffer (5% normal goat serum in TBS/Triton X-100 (0.1%))
for 30 min at RT. Incubation in primary antibody in blocking buffer occurred
overnight at 4o C. Antibody dilutions were: rabbit anti-Dcx: 1:1500; rabbit antiKi67 1:1000. On the following day, sections were washed with 1X TBS and
incubated in secondary antibody diluted in blocking buffer for 1hr at RT.
Secondary antibody dilutions were: goat anti-rabbit IgG FITC: 1:1000; goat antimouse IgG Cy5: 1:1000; goat anti-rat IgG Cy3: 1:1000. Sections were then
washed in 1X TBS prior to applying the coverslip with SlowFade Gold containing
DAPI (Invitrogen).
Labeled cells in the ipsilateral and contralateral inner granular layer (IGL)
of the dentate gyrus were summed from three sections (pre-epicenter, epicenter,
and post-epicenter at 400 µm intervals) using a Nikon Eclipse E600 fluorescence
microscope using a 40X objective. Dentate gyrus volume was estimated by
multiplying the area of the DAPI staining within the dentate gyrus (DG)
(measured by Image J (NIH) in collected images using a Zeiss Axiovert 200M
fluorescence microscope using a 10X objective) and multiplied by the thickness
of each section (40 µm). Cell density was then calculated by dividing total cell
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counts by the calculated volume of the DG. Representative images were taken
on a Nikon CKX31 A1 confocal microscope (20X objective).
Immunohistochemistry
Serial brain sections of 400 µm intervals were washed in 1X TBS, blocked
in blocking buffer (5% normal donkey serum in TBS/TritonX-100 (0.1%)) before
incubation with rabbit anti-NeuN 1:1000 or rabbit anti-GFAP 1:1000 in blocking
buffer overnight at 4o C. The following day sections were washed with 1X TBS
before incubation in biotinylated donkey anti-rabbit IgG 1:1000 for 1 hr at RT.
Sections were washed in 1X TBS and peroxidases were scavenged with 3% (v/v)
of 30% H2O2 in a 50/50 mix of methanol and water for 30 min at RT. Following
washing, sections were incubated in AB/TBS (Vector Laboratories) solution for 1
hr at RT. Immunostaining was visualized using cobalt-enhanced DAB (Vector
Laboratories), mounted, dried overnight, and dehydrated prior to application of a
coverslip with Permount media (Fisher).
Prior to application of the coverslip, CHI tissues were counterstained with
methyl green to allow analysis by Aperio Image-Scope XT digital slide scanner
and Aperio Image-Scope software. Tissue was mounted onto gelatin-coated
slides and dried overnight. The following day, tissue mounted slides were
incubated in ddH20 for 2 min, then in a 1:4 dilution of methyl green (from 0.5%
stock) in 0.1 M sodium acetate pH 4.2. Slides were washed with flowing H20 until
water ran clear. Slides were then dipped in 0.5% acetic acid in acetone 15 times
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to de-stain the tissue. Tissue then underwent EtOH dehydration prior to
application of the coverslip with Permount (Fisher).
Stereological Counts of Hippocampal CA-3
Stereological counting of mature neuronal cells from the dorsal
hippocampal CA-3 regions was conducted 10 d following CCI injury. Every 5th
brain section (200 µm intervals) spanning bregma levels -1.0 mm to -2.2 mm was
immunohistochemically labeled for NeuN and visualized with 60X oil immersion
objective on an Olympus BX-51 microscope equipped with a motorized stage
and stereology software (Bioquant Life Science. V8.40.20; Bioquant Image
Analysis, Nashville, TN). Unbiased counting was restricted to the dorsal
hippocampus as this is the area most affected by CCI and hippocampal
morphology and packing of the ventral CA-3 would require a different set of
sampling parameters. The dorsal CA-3 was overlaid with a counting grid (150 x
150 um2) and neurons counted within the set dissector area (20 x 20 um2) and
the total number of CA-3 neurons estimated by the equation, Σ= total cells
counted x 1/ssf x1/asf x 1/tsf, where ssf is the selection sampling fraction, asf is
the area sampling fraction and tsf is the thickness sampling fraction, as
previously described (Madathil, Carlson et al. 2013).
Neurological Severity Score (NSS)
NSS was performed by Jennifer Brelsfoard in the Spinal Cord and Brain
Injury Research Center at the University of Kentucky. Neurological severity score
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was performed at 1d, 2d, 3d, and 6d following CCI. Deficits in motor coordination
were analyzed as mice crossed beams of 3, 2, 1, and 0.5 cm width and a rod
0.5cm in diameter. Animals were acclimated to the assessment 24 hr prior to
injury, being allowed to explore the beams and rod for 30 sec. Following injury,
14 possible points were given for traversing the beams and rod with normal limb
movement. For beam traversing, points were deducted for footfalls, hanging
upside-down, and unwillingness to traverse (one point each). Falling from the
beam resulted in zero points. For the rod, one point was deducted for hanging
upside-down and inability to cross and two points for falling off the rod (Schoch,
Evans et al. 2012).
Novel Object Recognition (NOR)
NOR was performed by Jennifer Brelsfoard in the Spinal Cord and Brain
Injury Research Center at the University of Kentucky. Animals were individually
acclimated to a testing cage 24 hr prior to injury and allowed to freely explore for
1 hr. Following acclimation, the animals were introduced to two identical objects
placed on opposite sides of the cage and allowed to explore for 5 min. Seven
days following CCI, animals were returned to the testing cage for 1 hr before
reintroduction of two identical objects. Time exploring each object was recorded
over a 5 min period. After a 4 hr delay, the animal was returned to the testing
cage, where one of the familiar objects had been replaced with a novel object
and the time exploring each object was recorded for a 5 min period. Recognition
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index is calculated as time spent exploring the novel object divided by total
exploration time as previously described (Madathil, Carlson et al. 2013).
Radial Arm Water Maze (RAWM)
RAWM testing was performed as previously described with slight
modification (Alamed, Wilcock et al. 2006). Animals were tasked with locating a
platform submerged approximately 0.5 cm under water in one arm of a pool
containing 6 equally sized arms using visual cues surrounding the pool as a
guide. The mice were placed in the pool at different starting locations and given 1
min to locate the platform. If a mouse was unable to locate the platform within
that time, it was subsequently placed on the platform for 15 sec. Each of two
experimental days had 15 trials per mouse. Day 1 had alternating visual (1, 3, 5,
7, 9, 11) and hidden (2, 4, 6, 8, 10, 12-15) trials, whereas day 2 was consisted on
all hidden trials. During visual trials, an object was placed on the platform for
visualization. Errors were tallied for each time the animal entered the incorrect
arm of the maze and higher errors indicated more difficulty with the task. Mice
were tracked using the EthoVisionXT system. Graphed block data was quantified
by averaging the number of errors per hidden trial. Blocks 1-3 were derived from
the first day of training trials 2 & 4; 6, 8 & 10; and 12-15 respectively. Blocks 4-6
are calculated from the second day of testing by averaging trials 1-5, 6-10, and
11-15 respectively.
DLK Cloning
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DLK cloned within pDONR221 was purchased from the Arizona State
University plasmid repository. The DLK insertion was PCR amplified using the
following primers: 5’ – ATATGAATTCATATGGCTTGCCYCCAT - 3’ and 5’ –
ATATGCGGCCGCTCATGGAGGGAGGG - 3’ before being sub-cloned into
pCMV-Myc-N using the EcoRI and NotI restriction sites.
Cell Culture and Transfection
HEK-293T were grown in Dulbecco’s modified Eagle’s medium (DMEM,
Gibco) supplemented with 5% fetal bovine serum (FBS, Sigma), 100 U/ml
penicillin and 100 µg/ml streptomycin. Cells were maintained at 37o C in a
humidified atmosphere of 5% CO2. HEK-293T cells were transfected using
Transgin (Apharma) according to the manufacturer’s protocol. Briefly, 1x 106 cells
were seeded in a six-well plate 24 hr prior to transfection to yield a 70-80%
confluent dish for transfections. Lipid-DNA complexes were prepared mixing 2 µg
plasmid DNA with 2 µl Transgin reagent in 100 µl of Opti-MEM (Gibco) and
incubated at RT for 20 min. The lipid-DNA complexes were added drop-wise to
the cell monolayer after the growth media was replaced with 1 ml Opti-MEM.
Cells were incubated with lipid-DNA complexes for 4-6 hrs before the Opti-MEM
was replaced with fresh DMEM containing 5% FBS for 48 hrs prior to making
lysates.
Cell Lysate Preparation
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Transfected cells were lysed and harvested with RIPA buffer (40 mM
HEPES, 2 mM EDTA, 10 mM pyrophosphate, 10 mM glycerophosphate, 1%
sodium deoxycholate, 1% NP40, 0.1% SDS) and transferred to an ependorf tube
on ice. Lysates were cleared at 14,000 rpm. To prepare total protein lysates, 150
µg of protein lysate was mixed with 4X SDS-PAGE sample buffer (200 mM TrisHCl pH 6.8, 8% SDS, 40% glycerol, 4% β-mercaptoethanol, 50 mM EDTA, and
0.08% bromophenol blue).
Co-immunoprecipitation (Co-IP)
Protein G separose beads were washed with 10X volume of 1X PBS,
vortexed, and spun at 5,500 rpm followed by washing with 10X volume of lysis
buffer. Beads were resuspended in 200 µl lysis buffer with 4 µg FLAG antibody
per IP. Protein lysate (750 µg) was added to the separose/antibody mixture and
rotated at 4o C for 2 hrs. Following incubation beads were spun at 5,500 rpm and
the supernatant aspirated. Beads were then washed with lysis buffer once, lysis
buffer with 500 mM NaCl twice, and lysis buffer twice more. Bound proteins were
eluted by 5 min incubation at 100o C in 1X SDS-PAGE sample buffer. Bound
protein along with protein lysate (25 µg) and co-immunoprecipitation (1/2
reaction) was ran on a 12% SDS-PAGE gels, transferred onto nitrocellulose
membranes and subjected to immunoblotting with indicated antibodies.
Semi-quantification of Axonal Immunohistochemistry
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Optic nerve immunohistochemistry was performed similarly to
immunohistochemistry of brain sections using one 10 µm section of optic nerve
per animal. Sections were washed in 1X TBS/TritonX-100 (0.1%), and
peroxidases were scavenged with 3% (v/v) of 30% H2O2 in a 50/50 mix of
methanol and water for 30 min at RT. Following another set of washes, tissue
was incubated in blocking buffer (5% normal donkey serum in TBS/TritonX-100
(0.1%)) before incubation with mouse anti-SMI-32 1:1000 or rabbit anti-CD68
1:1000 in blocking buffer overnight at 4o C. The following day sections were
washed with 1X TBS/TritonX-100 (0.1%) before incubation in biotinylated donkey
anti-rabbit IgG 1:1000 or biotin donkey anti-mouse 1:1000 for 1 hr at RT.
Sections were washed in 1X TBS/TritonX-100 (0.1%). Following washing,
sections were incubated in AB/TBS (Vector Laboratories) solution for 1 hr at RT.
Immunostaining was visualized using cobalt-enhanced DAB (Vector
Laboratories), mounted, dried overnight, and dehydrated prior to application of
the coverslip with Permount (Fisher).
The entire optic nerve was imaged at 10X magnification in an AX-80 and
sequential images were merged to create a montage. Montages were overlaid
with a grid subdivided into 20 x 20 µm squares over 3200 µm of the nerve
beginning at the optic chiasm junction. Each square was scored for the presence
or absence of immunostaining and semi-quantitatively quantified by dividing the
number of squares positive for staining by the total grid squares overlaying the
nerve. Data are expressed as percent optic nerve grid-squares containing
positive staining.
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Quantification of Cortical Immunohistochemistry Using Aperio ImageScope
The Aperio ScanScope XT digital slide scanner was used to create a
single high-resolution image of the stained slides at a magnification of 20X. For
GFAP staining, 200 x 200 µm boxes were positioned along the neocortex using
the Aperio ImageScope software and the Aperio-positive pixel algorithm (version
9) was used to quantify positive pixels of specific staining that were then
normalized to the total pixel area outlined to account for variation in the size of
the region being sampled. For β−APP staining, areas of positive staining were
circled using the the Aperio ImageScope software and the Aperio nuclear
algorithm (version 9) to obtain the number of β−APP-positive axons and the total
neocortex was outlined and an area derived using the Aperio-positive pixel
algorithm (version 9). β−APP-positive axons were normalized to the total area to
obtain the number of β−APP-positive axons/mm2.
Tissue Homogenization and Mouse Cytokine ELISA
Following perfusion with PBS, the brain was removed and cut into two
hemispheres. The left hemisphere was post-fixed for immunohistochemistry
(refer to Tissue Preparation Section), the cortex of the right hemisphere was
dissected for ELISA. Lysis buffer (200 mM PMSF, 0.02% Halt and 0.5M EDTA in
1X PBS) was added at a volume of 20X the tissue weight and stored on ice
before homongenization for 30 s using an Omni TH homogenizer with plastic tip.
Samples were centrifuged at 12,000 X g for 20 min (Beckman Microfuge18) at 4o
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C. The supernatant was then aliquoted into a 96 well plate for long-term storage
at -80oC. A BCA assay was performed to determine the protein concentration of
each sample. Custom Mouse Cytokine kits were purchased from MSD to analyze
IL-1β, IL-6, IL-10, and TNF-α per the manufacturer protocol.
Statistical Analysis
All data are represented as mean ± SEM. Relevant statistics are
described in figure legends and generated using GraphPad Prism (unless
otherwise stated). In Chapter 3, numbers of FJC+ cells and volumetric cortical
tissue loss were analyzed using Student’s t-test. The density of Dcx+, and Ki67+,
BrdU+/Dcx+ neurons in dentate gyrus following CCI, NOR and NeuN+ cells in CA3 were analyzed using a two-way ANOVA followed by Bonferroni post-hoc when
appropriate. NSS was analyzed through non-parametric ANOVA at each time
point with Dunn’s comparison when appropriate. The level of statistical
significance was set at p < 0.05. Analysis of the optic nerve in Chapter 4 was
analyzed via ANOVA followed by Newman-Keuls post hoc test. Closed Head
Injury data in Chapter 5, was analyzed by ANOVA followed by Turkey-Kramer
post hoc test.

Copyright © Megan D. Pannell 2017
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CHAPTER THREE

Genetic Deletion of the Rin GTPase Promotes Neuronal Sparing and
Reduces Behavioral Deficits following Traumatic Brain Injury

Introduction
TBI is a progressive disorder, in which the primary injury results in the
initiation of a complex cascade of secondary biochemical and metabolic changes
leading to cell death and tissue damage that can persist and evolve over a period
of hours to weeks following the initial injury (McIntosh, Saatman et al. 1998,
Beauchamp, Mutlak et al. 2008, Borgens and Liu-Snyder 2012). The
hippocampus, which is critical for retrieval of short-term memory tasks and
episodic memory, is particularly vulnerable to the effects of TBI leading to
disruption of cognition, learning, and memory (Levin 1998, Kesner 2007,
Hunsaker, Lee et al. 2008). Imaging studies have identified a link between postTBI hippocampal atrophy and the severity of cognitive dysfunction	
  (Bigler, Blatter
et al. 1997, Ariza, Serra-Grabulosa et al. 2006). This same correlation is
observed in animal models of TBI, suggesting conservation of fundamental injury
mechanisms (Hicks, Smith et al. 1993, Fujimoto, Longhi et al. 2004). The
controlled cortical impact model (CCI) injury results in deficits in motor function,
learning, and memory (Fox and Faden 1998, Levin 1998, Saatman, Feeko et al.
2006). Hippocampal neuronal damage resulting from CCI is predominantly
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located in the dentate gyrus and cornu-ammonis-3 (CA-3) subregions of the
hippocampus	
  (Dixon, Clifton et al. 1991, Saatman, Feeko et al. 2006).
At a cellular level, cognitive impairment following TBI has not only been
correlated with hippocampal cell death, but also disruption of neurogenesis
(Rola, Mizumatsu et al. 2006, Cai, Carlson et al. 2012, Carlson, Madathil et al.
2014). Neurogenesis within the dentate gyrus of the hippocampus continually
generates new granule neurons that integrate into the circuitry throughout life
(Gage 2000). Neurogenesis is a dynamic process, and studies have
demonstrated that the levels of neurogenesis can be modulated numerous
factors including: age, sex, stress, growth factors, and environmental enrichment
(Kempermann, Kuhn et al. 1997, Ming and Song 2005, Ming and Song 2011,
Carlson, Madathil et al. 2014). Following TBI, immature (Dcx+) neurons within the
hippocampus are particularly vulnerable to secondary injury mechanisms and
undergo high levels of apoptosis (Rola, Mizumatsu et al. 2006, Gao, Deng-Bryant
et al. 2008). This setback in neurogenesis caused by immature neuronal loss is
thought to contribute the TBI-induced cognitive deficits (Yu, Zhang et al. 2008,
Blaiss, Yu et al. 2011). Brain injury also induces proliferation of neuronal stem
cells in the sub-granular zone of the hippocampus (Dash, Mach et al. 2001, Rola,
Mizumatsu et al. 2006). Increases in stem cell proliferation are thought to
contribute to enhancement of neurogenesis and allow the slow recovery of
immature neuronal numbers back to baseline levels, comparative to shaminjured controls (Rola, Mizumatsu et al. 2006). Establishing molecular
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mechanisms that contribute to neuroprotection of hippocampal neurons may
provide novel therapeutic strategies.
Together with their associated regulatory and effector protein networks,
Ras-related GTPases serve as master regulators of numerous cellular signaling
pathways, that contribute to almost every aspect of cellular physiology
(Wennerberg, Rossman et al. 2005). Ras family G-proteins are best known for
their functions in the regulation of cellular proliferation, differentiation, survival,
migration, and fate specification (Colicelli 2004, Wennerberg, Rossman et al.
2005). While the physiological role of many Ras family GTPases is known, there
remains a subset whose cellular functions have not been defined (Reuther and
Der 2000, Shi, Cai et al. 2013). This is the case for Rin (RIT2), which despite
sharing high levels of amino acid identity and significant overlap in known
downstream cellular effectors with the closely related Rit (RIT1) GTPase, would
appear to have a distinct cellular function as genetic deletion of RIT1 is not
complemented by endogenous RIT2 (Lee, Della et al. 1996, Wes, Yu et al. 1996,
Shao, Kadono-Okuda et al. 1999). Rit and Rin display distinct patterns of tissue
and developmental expression, with Rit expressed throughout development and
having a broad tissue distribution, while Rin expression is delayed to later stages
of embryonic neuronal development and proteomic data suggests Rin expression
is restricted to neuronal lineages (Lee, Della et al. 1996, Spencer, Shao et al.
2002, Cahoy, Emery et al. 2008, Sharma, Schmitt et al. 2015).
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Studies in cell lines have demonstrated that Rin is activated by growth
factor stimulation, contributes to TrkA-mediated p38 MAP kinase signaling in
pheochromocytoma cells, and modulates neurite outgrowth (Hoshino and
Nakamura 2002, Hoshino and Nakamura 2003, Shi, Han et al. 2005). However,
as many of these studies were performed in cells lacking endogenous Rin
expression, it is unclear whether these results accurately reflect the physiological
function of Rin (Shi, Cai et al. 2013). We have recently described an unexpected
role for Rit signaling in TBI-induced neurogenesis, functioning to promote
selective survival for immature hippocampal neurons following contusion brain
injury (Cai, Carlson et al. 2012). Because of similarities to Rit signaling, and its
distinct neuronal expression, we postulated that Rin would also contribute to
functional recovery following TBI. In this chapter, we use a novel transgenic RIT2
knockout mouse model; we show that following severe contusion brain injury, Rin
deficiency reduces regional hippocampal neurodegeneration and improves posttraumatic cognitive function.
Results
Genetic Rin loss does not alter brain morphology
Previous studies using cell culture models identified a putative role for Rin
in neuronal differentiation and stress signaling (Hoshino and Nakamura 2002,
Hoshino and Nakamura 2003, Shi, Han et al. 2005). These studies are limited by
the fact that only a few cell lines express endogenous Rin, making it unclear
whether the results accurately reflect in vivo Rin function	
  (Shi, Cai et al. 2013).
Therefore, to begin to characterize the physiological role of Rin signaling, we
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obtained a RIT2 knockout mouse from the Texas Institute of Genomic Medicine
(TIGM) generated using a gene trap insertion strategy (Figure 3.1A). Western
blot analysis from whole brain lysates was used to demonstrate the loss of
endogenous Rin protein in the gene trap line (Figure 3.1B). Rin-null mice were
born at expected Mendelian ratios and survived to adulthood with no apparent
physical or gross morphological abnormalities (data not shown). As available
evidence suggests that Rin is expressed solely within the nervous system (Lee,
Della et al. 1996, Wes, Yu et al. 1996), we further characterized gross brain
anatomy within a Rin null background. Overall brain structure was unaltered and
no obvious discrepancies in cell body (Nissl), mature neurons (NeuN), or
astrocyte (GFAP) distribution were observed (Figure 3.1C). Taken together,
these data indicate that Rin function is not essential for early neuronal
development or global brain architecture.
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Figure 3.1. Generation and characterization of Rin null-mutant mice. A.
Schematic representation of the Rit2 allele and gene trap VICTR 48 insert
utilized to generate Rin-/- mice. LTR, viral long terminal repeat; SA, splice
acceptor; NEO, neomycin resistance; pA, SV40 poly adenylation sequence;
PGK, phosphoglyserate kinase; BTK, first exon of the murine Bruton’s tyrosine
kinase gene; arrows indicate frt, flippase recognition targets, within the VICTR 48
insert. B. Western blot of brain lysates from wild-type (WT), Rin+/- and Rin-/- mice
demonstrating loss of Rin protein at both a short (top panel) and long exposure
(second panel) with no alterations to its closest homolog Rit (third panel). C.
Representative hemisphere images from naïve wild-type and Rin-/- mice stained
with GFAP, Nissl, and NeuN. Insets from of NeuN staining are included from the
cortex and hippocampal CA-1. No gross alterations in brain morphology or
development were noted due to global Rin loss.
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Rin deficiency promotes hippocampal cell survival
CCI injury results in robust cortical tissue loss at the injury site together
with acute degeneration of the underlying hippocampal structure that can be
analyzed using Fluoro-jade C (FJC) (Smith, Soares et al. 1995, Hall, Sullivan et
al. 2005, Rola, Mizumatsu et al. 2006, Gao, Deng-Bryant et al. 2008, Pleasant,
Carlson et al. 2011). To analyze the in vivo effect of Rin deficiency on
neurodegeneration following brain injury, we performed controlled cortical impact
(CCI) injury on cohorts of wild-type and Rin-/- mice. CCI resulted in hippocampal
degeneration concentrated primarily within the dentate gyrus regardless of
genotype. The volume of neocortical damage was equivalent for wild-type (13
±1%; n=4) and Rin-/- animals (13 ± 2%; n=6) (t-test, p=0.94) 48 hr following
moderate CCI. (Figure 3.2A). However, Rin-/- mice displayed significantly
diminished numbers of FJC-positive cells (WT 155 ± 13 cells n=5; Rin-/- 115 ± 12
cells, n=7, t-test p<0.05) (Figure 3.3 A, C). Sub-regional quantification revealed
that FJC-positive neurons trended downward in both the inner granular layer
(IGL), the location where immature neurons and neural stem cells reside, as well
as in the outer granular layer (OGL) of the dentate gyrus. Although fewer FJCpositive cells were observed in the CA1 or CA3 sub-regions, Rin loss was shown
to significantly attenuate CA3 cell death following CCI (WT 30 ± 4 cells n=5, Rin-/16 ± 3 cells, n=7; t-test p<0.05) (Figure 3.3A). FJC staining was not observed in
the hippocampus of sham-operated mice regardless of genotype.

	
  

62	
  

Figure 3.2. Cortical contusion volume changes equivalent in wild-type and
Rin-/- mice following contusive brain injury. A. Representative images of Nissl
stained brains demonstrating relative cortical loss in wild-type and Rin-/- animals
48 hr following CCI. B. Quantification of contralateral cortical volume compared
to the ipsilateral cortical volume demonstrates equal cortical damage in wild-type
and Rin-/- animals following head injury.
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Figure 3.3. Rin loss attenuated trauma-induced hippocampal
neurodegeneration. A. the dentate gyrus (DG), CA-1, and CA-3 regions of the
hippocampus and B. the outer granular layer (OGL) and inner granular layer
(IGL) suggest decreased degeneration within the dentate gyrus and CA-3 in the
absence of Rin. Data are presented as mean ± SEM (wild-type n= 5, Rin-/- n=7; ttest * p<0.05) C. Representative confocal images of the ipsilateral dentate gyrus
for wild-type and Rin-/- mice 48hrs following CCI co-stained with FJC (green) and
DAPI (blue).
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Rin deficiency does not alter the survival of newborn neurons in the
hippocampus following CCI
Immature neuronal numbers within the subgranular layer are reduced
acutely following CCI (Rola, Mizumatsu et al. 2006, Gao, Deng-Bryant et al.
2008); however, enhanced post-injury neurogenesis ensures the recovery of
newborn neuronal numbers in the weeks following CCI (Rola, Mizumatsu et al.
2006, Yu, Zhang et al. 2008, Carlson, Madathil et al. 2014). Because protection
was seen within the dentate gyrus of brain-injured Rin-/- mice, we next asked
whether Rin might contribute to the regulation of post-traumatic hippocampal
neurogenesis. BrdU/Dcx co-labeling detected equivalent numbers of newborn
immature neurons in naïve wild-type and Rin-/- mice 48h after the last of seven
daily BrdU injections, indicating that basal neurogenesis is unaffected by Rin
deficiency (Figure 3.4). However, concussive injury resulted in a marked
decrease of BrdU+/Dcx+ neurons in the ipsilateral dentate gyrus in wild-type mice
(27.4% reduction relative to shams 48hr post-CCI) (Figure 3.4B). An equivalent
reduction was observed in the ipsilateral dentate gyrus of Rin-/- mice (32.8%
reduction relative to sham) (Figure 3.4B). As expected, neuronal loss was
confined to the injured hemisphere and no alterations in contralateral BrdU+/Dcx+
cell numbers were observed regardless of genotype (Figure 3.4C).
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Figure 3.4. Rin loss had no effect on newborn neuron survival following
contusion injury. A. Representative confocal images at of wild-type and Rin-/mice labeled with Dcx (green), BrdU (red), and DAPI (blue). BrdU (50mg/kg) was
injected for 1 week prior to CCI or sham injury. The insets are at 5X higher
magnification; the arrowheads indicate BrdU/Dcx double positive cells. B.
Quantification of double-positive Dcx/BrdU cells 48hrs post-CCI in the ipsilateral
hemisphere show a main effect of injury [F(1,29)= 14.67, p<0.001] but not
genotype [F (1,29)=0.21, p=0.652] or interaction between genotype and injury [F
(1,29)=0.24, p=0.628] C. Quantification of double-positive Dcx/BrdU cells 48 hrs
post-CCI in the contralateral hemisphere show no main effect of injury [F(1,29)=
0.11, p=0.745], genotype [F (1,29)=0.30, p=0.589] or interaction between
genotype and injury [F (1,29)=0.01, p=0.924]. These data demonstrate that Rin
loss has no effect on immature neuronal cell death 48hr following TBI. Data
expressed as mean ± SEM (WT sham n=6, WT CCI n=8, Rin-/- sham n=7, Rin-/CCI n=12).
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Acute post-traumatic loss of immature neurons is followed by the
stimulation of neural progenitor cells, leading to increased hippocampal
neurogenesis and the return of immature (Dcx+) cell numbers to pre-injury levels
(Weinstein, Burrola et al. 1996, Gould and Tanapat 1997, Magavi, Leavitt et al.
2000, Kernie, Erwin et al. 2001). To determine whether Rin loss altered
progenitor cell proliferation in response to brain injury, we quantified cells within
the inner granular layer of the dentate gyrus actively in the cell cycle (Ki67+)
(Figure 3.5A). Wild-type and Rin-/- animals displayed similar increases in Ki67+
cells 48hr following trauma (WT 475%, Rin-/- 434%, increase compared to sham)
(Figure 3.5B). As expected, there was no TBI-induced increase in proliferation
contralateral to the injury (Figure 3.5C).
At 10 d post-CCI, total immature neuronal numbers (Dcx+ cells) in the
ipsilateral dentate gyrus of wild-type mice had returned to sham levels (WT sham
17 ±1.0 x103/mm3 cells, n= 6; WT CCI 19 ±2 x103/mm3 cells, n=8) (Figure 3.6A,
B). Rin-/- mice displayed a similar trend (Rin-/- sham, 16118 ±731 cells, n= 7; Rin-/CCI, 21258 ±1110 cells, n=7) (Figure 3.6B, C). In keeping with these results,
immature neuronal recovery (percent ipsilateral/contralateral Dcx+ cells) was
similar in wild-type and Rin-/- mice (Figure 3.6D). Taken together, these data
suggest that Rin function is not required for post-traumatic induction of
neurogenesis.
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Figure 3.5. Rin deficiency does not alter TBI-induced proliferation in the
inner granular layer of the dentate gyrus. A. Representative confocal images
of wild-type and Rin-/- mice labeled with Ki67 (red), and DAPI (blue). B.
Quantification of Ki67+ cells 48hrs post-CCI in the ipsilateral hemisphere show a
main effect of injury [F(1,15)= 135.67, p<0.0001] but not genotype [F (1,15)=0.98,
p=0.338] or interaction between genotype and injury [F (1,15)=0.199, p=1.79] C.
Quantification of Ki67+ cells 48 hrs post-CCI in the contralateral hemisphere
show no main effect of injury [F(1,15)= 4.08, p=0.062], genotype [F (1,15)=0.16,
p=0.698] or interaction between genotype and injury [F (1,15)=0.38, p=0.548].
Data are expressed as expressed as mean ± SEM (WT sham n=3, WT CCI n=5,
Rin-/- sham n=6, Rin-/- CCI n=6)
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Figure 3.6. Rin loss did not alter the recovery of immature neuron density
following controlled cortical impact A. Representative confocal images of
wild-type and Rin-/- mice labeled with Dcx (green) and DAPI (blue) 10 d following
CCI. B. Quantification of Dcx+ cells 10 d post-CCI in the ipsilateral hemisphere
show a main effect of injury [F(1,24)= 4.93, p<0.0361] but not genotype [F
(1,24)=0.02, p=0.8789] or interaction between genotype and injury [F
(1,24)=1.45, p=0.2339] C. Quantification of Dcx+ cells 10 d post-CCI in the
contralateral hemisphere show no main effect of injury [F(1,24)= 2.53, p=0.126],
genotype [F (1,24)=0.08, p=0.779] or interaction between genotype and injury [F
(1,24)=0.03, p=0.854] D. Recovery of immature neurons following CCI, quantified
as a percentage of Dcx+ cells on the ipsilateral dentate gyrus compared to the
contralateral side shows no change in recovery in the Rin-/- animals. Data are
expressed as mean ± SEM (wild-type sham n=6, WT CCI n=8, Rin-/- sham n=7,
Rin-/- CCI n=7).
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Rin deficiency promotes hippocampal CA-3 neuronal survival
To determine whether neuronal protection was sustained in Rin-/- mice, we
examined mature neuronal survival 10d following CCI within the CA-3 pyramidal
layer and dentate hilus (Figure 3.7). Stereological counts demonstrate that the
numbers of NeuN+ cells within the CA-3 (59.9% neuron loss relative to sham)
and hilus (64.7% neuron loss relative to sham) were markedly decreased in wildtype injured animals (Figure 3.7B, C). While the number of NeuN-positive
neurons was decreased in Rin-/- mice following injury, NeuN+ cell reduction was
significantly blunted in both the CA-3 (31.8% neuron loss relative to sham) and
hilus (50% neuron loss relative to sham) (Figure 3.7B, C).
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Figure 3.7. Rin loss promotes hippocampal neuronal survival following
brain injury. A Representative NeuN images of the ipsilateral hippocampus at
10d following severe CCI. B. Quantification of stereological estimates of total
mature neuronal cells in the dorsal ipsilateral hippocampus display neuronal
protection within the CA-3 10d after CCI [main effect of injury, F(1,16)= 102.03,
p<0.0001; main effect of genotype, F (1,16)=13.39, p=0.002; Interaction of
genotype and injury F (1,16)=8.63, p=0.0097; two-way ANOVA followed by
Bonferroni post-hoc, *p<0.05]. Data are expressed as mean ±SEM (WT sham
n=5, WT CCI n=6, Rin-/- sham n=4, Rin-/- CCI n=5). C. NeuN counts within the
ipsilateral hilus of the dentate gyrus display hilar protection. [main effect of injury,
F(1,16)= 170.12, p<0.0001; main effect of genotype, F (1,16)=6.13, p=0.025;
Interaction of genotype and injury F (1,16)=4.34, p=0.0535; two-way ANOVA
followed by Bonferroni post-hoc, *p<0.05). Data are expressed as mean±SEM
(WT sham n=5, WT CCI n=6, Rin-/- sham n=4, Rin-/- CCI n=5).

	
  

75	
  

Rin loss reduces post-CCI behavioral dysfunction
To determine whether the neuroprotection afforded by Rin loss correlated
with behavioral improvements following CCI, we evaluated motor function using a
modified neurological severity score (NSS) assay and hippocampal-mediated
cognitive performance through a novel object recognition (NOR) task (Schoch,
Evans et al. 2012, Madathil, Carlson et al. 2013). Both wild-type and Rin-/- shaminjured animals performed equivalently suggesting no baseline motor or cognitive
defects (Figure 3.8). Brain injured cohorts displayed significant loss of motor
coordination regardless of genotype as indicated by low NSS scores in the days
following injury, which were equivalent at each time point assessed (Figure
3.8A). Cognitive evaluation demonstrated significant impairment in wild-type
mice following severe CCI as indicated by a recognition index of 51.6 ± 5.0%,
which indicates no preference for the novel object over a familiar one (Figure
3.8B). Rin-/- brain-injured mice, however, displayed cognitive sparing as
indicated by a recognition index of 66.3 ± 2.7%, a score more closely resembling
sham groups (WT sham 72.4 ± 2.4%, n=10; Rin-/- sham 72.6 ±1.8%, n=8)
(Figure 3.8B). These data suggest that Rin loss led to improved memory of the
familiar object.
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Figure 3.8. Rin loss reduced cognitive impairment after CCI A. Neurological
severity score, derived from a series of beam walking tasks, showed no
difference in motor function at 24 hr to 6 d following CCI. Data are expressed as
mean ± SEM (Non-parametric Kruskal-Wallis test; WT sham n=10, WT CCI
n=10, Rin-/- sham n=9, Rin-/- CCI n=8) B. Novel object recognition cognitive
paradigm in wild-type and Rin-/- mice suggest enhanced cognition of Rin-/- mice at
7 d after severe CCI injury [main effect of injury, F(1,32)= 15.6, p<0.001; main
effect of genotype, F (1,32)=4.64, p=0.039; Interaction of genotype and injury F
(1,32)=4.43, p=0.043; two-way ANOVA followed by Bonferroni post-hoc,
*p<0.05]. Recognition index is represented as the percentage of time exploring
the novel object; the dotted line represents a recognition index of 50%; data
represented as mean ± SEM (WT sham n=10, WT CCI n=10, Rin-/- sham n=8,
Rin-/- CCI n=8.
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Discussion
Here for the first time, we implicate Rin GTPase function in the regulation
of neuronal cell loss following TBI. Because the hippocampus has been
described as particularly vulnerable to contusive brain injury (CCI) (Levin 1998,
Rola, Mizumatsu et al. 2006) we focused our characterization on post-traumatic
neuroprotection within this structure. Employing a novel transgenic RIT2
knockout mouse model, we demonstrate that Rin deficiency promotes
hippocampal neuronal protection, in addition to improving cognitive function
following severe brain injury. However, Rin loss does not affect post-injury
hippocampal neurogenesis, suggesting a key role for Rin in the regulation of
mature neuron cell loss following TBI.
Previous work from this lab has identified important roles for Rit GTPase
signaling in the regulation of both insulin-like growth factor-1 (IGF-1) and traumainduced neurogenesis (Mir, Cai et al. 2017, Mir, Cai et al. 2017). RIT1-/transgenic mice exhibit an increased loss of adult-born immature hippocampal
neurons after severe brain injury (Cai, Carlson et al. 2012). Furthermore,
neuronal-selective expression of constitutively activated Rit has been
demonstrated to increase levels of basal neurogenesis in the subgranular zone
of the hippocampal dentate gyrus (Mir, Cai et al. 2017). Additionally, its loss
promotes neuronal death in response to oxidative stress (Cai, Carlson et al.
2012), thus demonstrating a role for Rit in the regulation of activity-dependent
plasticity and general neuronal survival. The finding that Rin deficiency had no
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effect on injury-induced neurogenesis or immature neuronal survival
demonstrates that Rit and Rin have distinct physiological roles in the
hippocampus. Divergent functions of these closely related GTPases was not
entirely unforeseen given that a constitutively active mutation of Rin failed to
promote transformation of NIH-3T3 (Rusyn, Reynolds et al. 2000), and that RIT1
deletion results in a neuronal phenotype that cannot be complemented by RIT2
or any other Ras family GTPase (Cai, Rudolph et al. 2011). What is surprising is
that our studies suggest that while Rit serves as a critical regulator of an
important survival mechanism for cells in response to stress (Cai, Rudolph et al.
2011, Shi, Cai et al. 2013), Rin would appear to play diametrically opposite role
in neurons, promoting neuronal loss in response to injury. Further studies are
needed to decipher the molecular underpinnings that confer independent roles
for Rin and Rit in the CNS.
Post-trauma restorative neurogenesis and neuronal survival within the
hippocampus have been reported to be important mediators of post-traumatic
outcomes (Levin 1998, Madsen, Kristjansen et al. 2003, Kesner 2007, Hunsaker,
Lee et al. 2008, Jessberger, Clark et al. 2009, Blaiss, Yu et al. 2011). The finding
that Rin loss promotes neuroprotection in the CA-3 and hilar sub-regions of the
hippocampus 10 d post-CCI (Figure 3.6), without altering neurogenesis (Figure
3.3, 3.4, 3.5), supports a selective role for endogenous Rin in the regulation of
molecular cascades that promote neuronal loss following brain-injury.
Furthermore, these data suggest that enhanced mature neuron survival is the
primary mechanism for cognitive sparing seen in our Rin-/- transgenic model.
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Studies are underway to determine whether Rin silencing serves to decrease cell
loss following brain injury.
Interestingly, although Rin loss was not shown to alter immature neuronal
numbers within the hippocampus following injury, there does appear to be a
reduction in ectopic migration of Dcx+ neurons in the granular layer (Figure 3.5).
Ectopic migration of Dcx+ cells has been reported at 7 d in models of focal TBI
(Shapiro 2017); however, the consequences of aberrant hippocampal cell
migration are not completely characterized in models of TBI. Epilepsy, however,
is characterized by abnormal integration of hippocampal dentate granule cells
(Hester and Danzer 2014). Inappropriate axonal contacts of irregularly migrating
cells have been demonstrated to form dysregulated recurrent excitatory loops,
and it is believed that abnormal neurogenesis may be epilepyogenic (Hester and
Danzer 2014). Closer examination of Dcx+ migration in Rin-/- mice is needed to
elucidate the potential role for Rin in immature neuronal migration. However,
limiting ectopic cell migration following injury may also be an avenue of protection
in the absence of Rin.
Furthermore, we have demonstrated that Rin deficiency leads to cognitive
behavioral sparing following severe contusion injury, but does not improve
coordinated motor function. Improved cognitive function is consistent neuronal
sparing observed throughout the hippocampus (Figures 3.3, 3.7B), a critical
structure for many aspects of learning and memory. Motor movements are
greatly controlled within the cortex, and it has been previously noted that the
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degree of motor impairment following injury is correlated with cortical injury
volume (Tsenter, Beni-Adani et al. 2008). In these studies, wildtype and Rin null
mice displayed equivalent cortical loss following injury (Figure 3.2); therefore, it
is not surprising that Rin loss did not lead to motor improvements (Figure 3.7A).
The question of why Rin loss selectively protects hippocampal but not cortical
neurons remains to be answered.
The notion that endogenous Rin is involved in the regulation of molecular
cascades that control neuronal loss following injury is striking given that many of
Ras subfamily GTPases are known to function in cell survival (Colicelli 2004,
Wennerberg, Rossman et al. 2005). Nonetheless, Ras GTPase-regulated MAPK
cascade activation has been found to regulate cell death and autophagy
pathways that in turn play central roles in neuronal survival signaling (Donninger,
Calvisi et al. 2015, Cook, Stuart et al. 2017, Zhang, Zheng et al. 2017). ERK,
JNK, and p38 MAPK signaling cascades have been described as mediators of
cell death following focal ischemic injury and their inhibition shown to improve
outcomes following injury (Sugino, Nozaki et al. 2000, Nozaki, Nishimura et al.
2001, Yang, Gu et al. 2017). Interestingly, ERK activation has been
demonstrated to have a pro-apoptotic role in mature neurons; however, ERK
phosphorylation is not observed during immature neuronal death (Lesuisse and
Martin 2002). Previous studies from the lab demonstrate a role for Rin in ERK
activation (Shi, Han et al. 2005). Furthermore, studies have identified a
prominent role for Rin in p38 stress kinase signaling, as RNAi-mediated Rin
silencing was found to disrupt p38 activation downstream of nerve growth factor
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in pheochromacytoma cells (Shi, Han et al. 2005). Further studies are needed to
characterize the activation of MAPK signaling cascades in our transgenic Rin null
mice following contusive brain injury model. Studies are underway to determine
whether expression of a constitutively active Rin mutant is able to modulate
neuronal MAPK signaling.
In this chapter, we have identified a novel role of Rin following severe
focal contusion by demonstrating increased hippocampal neuroprotection and
improved cognition following genetic silencing of Rin. These results suggest a
role for Rin signaling cascades leading to cell death following severe focal injury
and suggest Rin as a possible therapeutic target following TBI. The severe
nature of the CCI injury model makes it difficult to parse out the contributions of
Rin to specific secondary injuries following TBI. Therefore, in the chapters to
follow, we have employed alternative experimental injury models that allow us to
analyze the role of Rin in axonal degeneration along white matter tracts and
neuroinflammation.

Copyright © Megan D. Pannell 2017
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CHAPTER FOUR

Rin Contributes to Trauma-induced Axonal Injury

Introduction
Traumatic axonal injury (TAI) is a common feature of diffuse TBI, generally
resulting from high-velocity rotational forces that result in stretching and shearing
of axons, and although severe injury can lead to primary axotomy, more often the
injury manifests as a interruption of protein transport and breakdown of
cytoskeletal elements (Hill, Coleman et al. 2016). These events activate
secondary injury cascades which, if not resolved, leads to disconnection of the
distal axon at the site of injury and its eventual degeneration (Hill, Coleman et al.
2016). Disruption of white matter tract integrity contributes to cognitive and motor
impairments observed following TBI, and white matter degeneration has been
shown to persist years following the initial insult (Johnson, Stewart et al. 2013).
The key histological components of TAI include retraction bulbs and axonal
swellings that result from a breakdown of microtubules and an accumulation of
proteins in the axon due to impaired protein transport (Tang-Schomer, Johnson
et al. 2012). Although disruption of the axonal cytoskeletal structure and transport
can lead to neuronal cell death, this is not always the case. Recent research
suggests that, over time, diffuse axonal damage can be corrected through
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reorganization and repair of the proximal axon following disconnection (Wang,
Fox et al. 2013).
Primary axotomy is generally considered to be an uncommon feature of
TAI unless the injury was the result of by direct tissue injury, such as laceration
(Christman, Grady et al. 1994). In these cases, the axon is divided into two parts:
a proximal portion that remains attached to the cell body and a distal stump that
has lost its connection to the nucleus. Eventually, the distal stump will inevitably
undergo degeneration. Historically it was believed that the wasting away of the
distal axon was a passive process, or a consequence of separation from the cell
body and occurred when the axon lost essential proteins that could no longer be
synthesized (Gerdts, Summers et al. 2016). However, the discovery of the
Wallerian degeneration slow (Wlds) mutant mouse challenged this dogma (Lunn,
Perry et al. 1989, Glass, Brushart et al. 1993). It was found that in this mutant,
arising from a fusion between a metabolic cofactor, nicotinamide mononucleotide
adenylyl transferase 1 (NMNAT1), and an ubiquitin ligase, ubiquitination factor
e4b (Ube4b), axonal degradation following axonal transection was delayed for up
to three weeks (Wang, Medress et al. 2012, Gerdts, Summers et al. 2016).
Although the protective mechanism of the Wlds chimera is still unclear, it has
been demonstrated that increased NMNAT1 activity and NAD+ levels contribute
to axonal protection following injury (Araki, Sasaki et al. 2004). Indeed,
manipulations that increase axonal expression of NMNAT1 (Sasaki, Vohra et al.
2009, Babetto, Beirowski et al. 2010) or direct transduction of NMAMT into
severed axons acutely following injury (Sasaki and Milbrandt 2010) have been
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shown to confer axonal protection. Following TBI, Wlds mutant mice display
decreased axonal injury and delayed cognitive and motor impairment (Fox and
Faden 1998) suggesting a potential therapeutic outlet against the detrimental
outcomes of TAI once the molecular mechanisms of the chimera are understood.
Nevertheless, the Wlds mouse encodes a gain-of-function mutation and, in
itself, does not reveal the presence of a pro-degenerative program; however if
degenerative cascades exist, then loss of these signaling components should
provide protection from axonal degradation (Gerdts, Summers et al. 2016). The
first protein identified as a candidate within a conserved axonal pro-degenerative
pathway was dual leucine zipper kinase (DLK), a mitogen-activated protein
kinase kinase kinase (MAPKKK) (Miller, Press et al. 2009). Genetic deletion of
DLK has been demonstrated to transiently delay axonal degeneration of the
sciatic nerve following injury, slowing Wallerian degeneration (Miller, Press et al.
2009). Since its identification, DLK has been shown to control a multitude of
seemingly opposing neuronal processes including not only Wallerian
degeneration and cell death, but also axonal regeneration and growth {reviewed
in (Tedeschi and Bradke 2013)}. However, the regulatory proteins and effectors
that allow for DLK to function in apparently contradictory roles are not completely
characterized.
Early biochemical analysis shows that overexpression of DLK activates
the stress-activated protein kinases (SAPK), JNK, and p38; signaling through
these pathways is largely involved in responses to cellular stressors, such as
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osmotic stress, UV irradiation, hypoxia, oxidative stress, and pro-inflammatory
cytokines, and SAPK activation often leads to cell death (Fan, Merritt et al. 1996,
Tibbles and Woodgett 1999). Ras family GTPases are known regulators of p38
and JNK signaling pathways (Robinson and Cobb 1997), suggesting that a Ras
family GTPase may lie upstream of DLK. However, one has not been described
to date. Rin GTPases have been found to activate p38 stress kinase signaling
(Shi, Han et al. 2005), and their loss promotes neuronal survival (Chapter 3),
indicating that Rin signaling promotes cell death. These observations suggest
that Rin may be able to bind and activate DLK.
My previous research has indicated that the loss of Rin protects mature
neurons from death following contusive brain injury. Furthermore, protection
provided by Rin loss was shown to occur at particularly high levels within the CA3 region of the hippocampus following contusive TBI (Chapter 3). Because
neurons within the hippocampal CA-3 region are suggested to undergo a high
degree of stretch following CCI injury (Mao, Elkin et al. 2013) we hypothesized
Rin loss diminished axonal injury leading to neuronal protection. Herein, we test
the hypothesis that Rin signals through a pro-degenerative cascade, with the
implication being that genetic deletion of RIT2 will result in decreased axonal
degeneration following trauma. To test this hypothesis, we employed both an
optic nerve stretch injury model to produce axonal degeneration across the optic
nerve to investigate the role of Rin in axonal breakdown (Saatman, Abai et al.
2003, Serbest, Burkhardt et al. 2007), and an optic nerve transection model to
investigate the role of Rin in Wallerian degeneration.
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Results
Rin loss mitigates trauma-induced axonal degeneration following stretch
injury
To test the hypothesis that Rin loss would protect neurons from traumatic
axonal injury, we performed optic nerve stretch on cohorts or wild-type and Rin-/mice to generate an isolated white matter tract injury along the optic nerve (Smith
2000, Saatman, Abai et al. 2003). The optic nerve stretch model allows analysis
of isolated trauma-induced axonal damage circumventing difficulties of targeting
white matter tracts in the brain, which has a more complex anatomy (Saatman,
Abai et al. 2003). In this model, rapid unilateral stretch of retinal ganglion axons
causes damage to the elements of the axonal cytoskeleton, the major component
of which are neurofilaments (Smith 2000). Following stretch, the region of the
optic nerve spanning between the globe of the eye and optic chiasm was
examined for injury using SMI-32, a marker of dephosphorylated neurofilament, a
well-established marker of axonal/neurofilament damage (Christman, Grady et al.
1994). At 24hrs following injury, minute accumulation of SMI-32 can be observed
throughout the optic nerve of injured axons in both wild-type and Rin-/- animals
(Figure 4.1A) suggesting equivalent intensities of injury in each genotype.
However, levels were not significantly higher than sham controls, consistent with
the progressive nature of this injury (Saatman, Abai et al. 2003) (Figure 4.1B).
By 7d post-stretch injury, degeneration progressed along the optic nerve,
exhibited by an increase of SMI-32 positive immunostaining in injured wild-type
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animals compared to wild-type sham controls (p<0.001 one-way ANOVA
followed by Newman-Keuls post-hoc test) (Figure 4.2). Rin null sham and injured
mice displayed equivalent levels of SMI-32 accumulation along the optic nerve
suggesting that Rin loss blocks the progression of axonal injury. This finding is
further illustrated by a significant decrease of SMI-32 staining in Rin-/- mice
compared to wild-type following injury (p<0.05 one-way ANOVA followed by
Newman-Keuls post-hoc test) (Figure 4.2B). Taken together these data suggest
that although both wild-type and Rin null animals displayed some degree of acute
injury, Rin loss reduces the progression of degeneration.
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Figure 4.1. Rin loss does not alter early axonal degeneration 24 hr following
optic stretch injury. A. Representative images of dephosphorylated
neurofilament (SMI-32) in the optic nerve 24 hrs following optic stretch injury in
wild-type and Rin-/- animals. B. Quantification of SMI-32 in the optic nerve
following injury indicates that early degeneration between wild-type and Rin-/animals are comparable 24 hr following stretch injury. Data are expressed as
mean ± SEM (wild-type n=6-12, Rin-/- n=5-11; ANOVA followed by NewmanKeuls post hoc test p>0.05.
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Figure 4.2. Rin loss blunts axonal degeneration 7 d following optic stretch
injury. A. Representative images of dephosphorylated neurofilament (SMI-32) in
the optic nerve 7 d following optic stretch injury in wild-type and Rin-/- animals. B.
Quantification of SMI-32 in the optic nerve following injury indicates that Rin loss
blunts the progression of axonal damage following stretch injury. Data are
expressed as mean ± SEM (wild-type n=6-12, Rin-/- n=5-11; ANOVA followed by
Newman-Keuls post hoc test *p<0.05.
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Rin loss diminishes trauma-induced microglia activation following optic
stretch injury
Because Rin null mice displayed decreased axonal degeneration following
stretch, we hypothesized that microglial activation would also be blunted. Postinjury inflammation was analyzed using immunohistochemical detection of cluster
of differentiation 68 (CD-68), a marker for activated microglia. At 24hrs following
injury, minimum accumulation of CD-68 was detected throughout the optic
nerves of both wild-type and Rin-/- stretch-injured mice (Figure 4.3A) in
agreement with the minute degree of axonal injury observed via SMI-32 labeling.
Once again, there was no statistical difference between sham and injured
cohorts (Figure 4.3B).
By 7d post-stretch robust microglial activation was observed along the
optic nerve demonstrated by an increase of CD-68 positive immunostaining in
the injured wild-type cohort compared to wild-type sham controls (p<0.01 ANOVA
followed by Newman-Keuls post-hoc test) (Figure 4.4). However, Rin-/- sham and
stretch-injured mice displayed equivalent levels of microglial activation along the
optic nerve. This finding is further illustrated by a significant decrease in
microglial activation in Rin-/- mice compared to wild-type cohorts following injury
(p<0.05 ANOVA followed by Newman-Keuls post-hoc test) (Figure 4.4B).
Furthermore, a strong correlation was found between the degree of axonal
degredation (SMI-32 positive immunostaining) and microglial activation (CD-68
positive immunostaining) (Pearson’s coefficient 0.72) (Figure 4.5). Together
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these data suggest that the diminishment of axonal injury in Rin null mice results
in a reduced need for microglial activation post-injury.
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Figure 4.3. Rin loss does not alter early microglial activation 24 hr following
optic stretch injury. A. Representative images of phagocytic macrophages (CD68) in the optic nerve 24 hrs following optic stretch injury in wild-type and Rin-/animals. B. Quantification of CD-68 in the optic nerve following injury indicates
that early inflammation between wild-type and Rin-/- animals are comparable 24
hr following stretch injury. Data are expressed as mean ± SEM (wild-type n= 612, Rin-/- n= 5-11; one-way ANOVA followed by Newman-Keuls post hoc test p
>0.05.
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Figure 4.4. Rin loss blunts microglia activation 7 d following optic stretch
injury. A. Representative images of phagocytic macrophages (CD-68) in the
optic nerve 7d following optic stretch injury in wild-type and Rin-/- animals. B.
Quantification of CD-68 in the optic nerve following injury indicates that Rin loss
blunts inflammatory responses 7d following stretch injury. Data are expressed as
mean ± SEM (wild-type n=6-12, Rin-/- n=5-11; one-way ANOVA followed by
Newman-Keuls post hoc test **p<0.01.
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Figure 4.5. Relationship between axonal damage (SMI-32) and microglial
activation (CD-68) following optic stretch injury. The percent area of SMI-32
and CD-68 coverage on the optic nerve following injury displays a high degree of
correlation. r2= 0.7215

	
  

96	
  

Rin interacts with the MAPKKK, Dual Leucine Zipper Kinase (DLK)
Levels of DLK have been determined to increase following injuries to the
optic nerve (Watkins, Wang et al. 2013) leading to subsequent activation of JNK
and the downstream transcription factor, c-Jun (Chen, Rzhetskaya et al. 2008,
Ghosh, Wang et al. 2011, Watkins, Wang et al. 2013, Welsbie, Yang et al. 2013).
Given that MAPK cascades, including JNK, are known to be regulated by Ras
family GTPases, we sought to determine if Rin could lie in this pathway (Figure
4.6A). To determine whether Rin was a possible upstream regulator of DLK, we
performed co-immunoprecipitation experiments in HEK-293T cells by
overexpressing Myc tagged DLK and FLAG tagged GTPase constructs (Rin, Rit,
and H-Ras). Rin and Rit share a high degree of sequence similarity, including an
identical effector domain, whereas the effector domain of H-Ras, a closely
related Ras protein, has a distinct, yet still structurally similar effector loop
(Figure 4.6B). Both Rin and Rit were found capable of co-immunoprecipitating
with DLK (Figure 4.6C lane 3 & 4). H-Ras, however, did not interact with DLK
(Figure 4.6C lane 5). These data suggest that Rin and Rit could potentially lie
upstream of the DLK cascade and ablation of these proteins could alter DLKmediated signaling.
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Figure 4.6. Rin associates with Dual Leucine Zipper Kinase (DLK), an
upstream regulator of axonal degeneration. A. Schematic representation of
the DLK MAPK cascade, which has been demonstrated to signal axonal
degeneration following injury, and the hypothesis that Rin GTPase lies upstream
of DLK activation. B. Amino acid alignment of the G2 effector domains of Rin, Rit
and H-Ras. C. HEK-293T cell co-immunoprecipitation between DLK and Rin, Rit
and H-Ras shows interaction between the Rit sub-family of GTPases with DLK,
but no interaction with H-Ras.
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Transection-induced Wallerian degeneration unaffected by Rin loss
Because Rin loss reduced axonal degeneration following stretch injury
and literature has demonstrated a role for DLK in pro-degenerative cascades
following optic injury (Miller, Press et al. 2009, Tedeschi and Bradke 2013, Yang,
Wu et al. 2015), we sought to determine whether the loss of Rin could delay
Wallerian degeneration. Resolution of this question, however, could not be
adequately provided using the optic nerve stretch model. The diffuse nature of
the stretch injury, which causes breaks throughout length of the optic nerve does
not allow for analysis of the directionality of axonal breakdown or permit
distinction between the proximal and distal axons. Also problematic is the notion
that every axon does not receive an equivalent injury and stretch injury does not
immediately lead to axonal disconnection. Therefore, we used axonal transection
of the optic nerve to generate a localized, normalized injury to assess the impact
of Rin loss on Wallerian degeneration.
Following transection in wild-type and Rin-/- mice, axonal degeneration
was analyzed by immunostaining for SMI-32. At 24 hr post-transection,
equivalent SMI-32 positive immunostaining was observed in the distal nerve of
both wild-type and Rin-/- mice (Figure 4.7). By 7 d post-transection, axonal injury
had spread all the way to the optic chiasm in both wild-type and Rin-/- animals.
These data suggest that Rin loss does not result in a dramatic alteration in the
rate of Wallerian degeneration in the distal axon following transection.
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Figure 4.7. Rin loss has no effect on axonal degeneration 24hr following
optic nerve transection. Representative images of the dephosphorylated
neurofilament (SMI-32) in the optic nerve 24 hr following optic transection at 4X
magnification show comparable progression of axonal degeneration from the site
of transection (on the right side of the image). The contralateral nerve was used
as a negative control. (Wild-type n=4 and Rin-/- n=4).
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Figure 4.8. Rin loss has no effect on axonal degeneration 7d following optic
nerve transection. Representative images of the dephosphorylated
neurofilament (SMI-32) in the optic nerve 7 d following optic transection at 20X
magnification show comparable progression of axonal degeneration from the site
of transection. Images are taken at the optic chiasm and indicate that axonal
degradation has progressed along the entire optic nerve by 7 d. (Wild-type n=4
and Rin-/- n=4)
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Discussion
In the present chapter, our data support a role for Rin in pro-degenerative
cascades following trauma-induced axonal stretch injury. We demonstrate that
the loss of Rin blunts axonal degeneration (Figure 4.2) and diminishes traumainduced inflammation (Figure 4.4). In looking to identify the molecular cascade
downstream of Rin that might be involved in axonal degeneration, we identified a
direct interaction with DLK (Figure 4.6). As DLK has been should to play a
critical role in Wallerian degeneration, we also examined the effect of Rin loss on
the degeneration of distal axons following optic nerve transection (Figures 4.7
and 4.8). While not conclusive, these preliminary transection studies suggest that
Rin is not required for Wallerian degeneration.	
  
A growing body of evidence indicates that axonal degeneration results
from a complex interplay between proteins promoting axonal survival and
degeneration, suggesting axonal integrity is a dynamically regulated process that
can be therapeutically exploited (Gerdts, Summers et al. 2016). Using the power
of Drosophila genetics to unravel the molecular process(es) underlying Wallerian
degeneration, DLK was identified as one of the first pro-degenerative proteins,
whose inhibition delayed acute axonal degeneration (Miller, Press et al. 2009).
Subsequent studies identified two other MAPKKKs, MEK2 and MEKK4, that are
also involved in axonal breakdown through activation of JNK (Yang, Wu et al.
2015). Furthermore, MAPK activation has been demonstrated to increase the
turnover of SCG10, an axonal survival protein within the axon, to speed
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degeneration (Shin, Miller et al. 2012). Herein, we have demonstrated an
interaction between Rin and DLK through co-immunoprecipitation (Figure 4.6)
and provided strong evidence that Rin loss blunts axonal degeneration following
a stretch model of traumatic injury (Figure 4.1 and 4.2). These data suggest a
possible role for Rin upstream of the MAPK pro-degenerative cascade. However,
more research is needed to support this hypothesis and demonstrate Rin
dependent activation of JNK and turnover of SCG10.
It should be noted that the linkage between Rin and the degenerative
MAPK cascade might not necessarily be direct. Although no Ras GTPase has
been demonstrated to regulate DLK, Rho family GTPases (Rac and Cdc42) have
been demonstrated to signal through DLK (Fan, Merritt et al. 1996). Indeed, the
ability of constitutively active mutations of Rac1 and Cdc42 to signal through
SAPK pathways is significantly inhibited by expression of catalytically inactive
DLK (K185A) (Fan, Merritt et al. 1996). This does not negate the possibility of Rin
upstream of DLK as there are many ways to regulate any signaling pathway.
Therefore, Rin may still directly activate DLK. It is also possible that Rin could
indirectly signal through the degenerative MAPK cascades. Rin overexpression
has been demonstrated to activate Rho family GTPases, including both Rac1
and Cdc42 (Hoshino and Nakamura 2003); therefore, it is possibly that Rin may
control DLK upstream of the Rho family of GTPases.
More recently, Sarm1 has been implicated in axonal breakdown and its
loss is associated with axonal survival weeks following TBI and sciatic nerve
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injury (Osterloh, Yang et al. 2012, Gerdts, Summers et al. 2013, Henninger,
Bouley et al. 2016). Furthermore, its activation is sufficient to induce axonal
degeneration in the absence of external injury (Gerdts, Summers et al. 2013,
Gerdts, Brace et al. 2015, Yang, Wu et al. 2015), suggesting it is a central
regulator of Wallerian degeneration. NMNAT is a critical enzyme for NAD
biosynthesis from ATP and nicotinamide and has been demonstrated to protect
against axonal degeneration (Sasaki and Milbrandt 2010, Jayaram, Kusumanchi
et al. 2011). NMNAT2 is a survival protein that is continually turned over and
transported to the axon through anterograde transport (Gilley, Orsomando et al.
2015). It has been demonstrated that the loss of NMNAT2 expression within the
axon due to inhibition of anterograde transport triggers Sarm1 activation	
  (Gilley,

Orsomando et al. 2015, Sasaki, Nakagawa et al. 2016) which then depletes

axonal stores of NAD+ leading to a metabolic disaster (Yang, Wu et al. 2015).
Recently it has been suggested that these two models, MAPK and Sarm1, are
intertwined in the control of Wallerian degradation following a demonstration that
MAPK cascades signal upstream of Sarm1 (Walker, Summers et al. 2017).
Unification of the pro-survival and pro-degenerative responses into a single
pathway suggests that Rin signaling may lie upstream of Sarm1 and analyzing its
effect on NMNAT levels and NAD+ depletion following traumatic injury could
provide a better understanding of the long-term protection seen in Rin null
animals following optic stretch. If Rin lies upstream of the MAPK/Sarm1
pathways, then expression of constitutively activated Rin should mediate cell
death and axonal degeneration, increasing JNK activation, Sarm1 activation,
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depletion of NMNAT2, and NAD+ depletion. In the absence of Rin these
pathways should be down regulated, diminishing metabolic catastrophe following
optic nerve damage.
Herein we demonstrated that Rin loss was able to lessen degeneration
associated with axonal stretch induced TAI (Figure 4.2), but had no obvious
effect following axon transection (Figures 4.7, 4.8). We propose that this may be
due to inherent differences between the two models of injury. Optic stretch is a
less severe form of TAI, resulting in disruption of axonal transport. Protein
accumulation in the axon, if not alleviated, leads to axonal breakage and
retraction. This process is slow compared to the immediate axotomy caused by
transection of the optic nerve. Currently the upstream stimuli capable of Rin
activation following traumatic brain injury are unknown. Therefore, it is feasible
that Rin would be activated following stretch but not following primary axotomy.
However, inhibition of stress MAPK cascades has been shown to delay Wallerian
degeneration for a matter of hours; therefore, it is possible that Rin plays a role in
Wallerian degeneration that we missed. Future studies should examine
degeneration at time points closer to the time of injury, as more modest
protection may not last for 24hrs. Further studies are needed to more thoroughly
examine Wallerian degeneration in the absence of Rin before any final
conclusion can be drawn.
In summary, the data presented in this chapter demonstrates a role for Rin
in trauma-induced axonal injury, as its loss blunts both axonal degeneration and
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microglial activation up to 7d following injury. This data is in line with our previous
finding that Rin loss decreases cell death within the CA-3 region of the
hippocampus (Figure 3.7), an area suggested to undergo a higher degree of
stretch following CCI injury (Mao, Elkin et al. 2013). This data suggests the
intriguing possibility that the neuronal protection afforded by Rin loss identified in
Chapter 3 may result from decreased axonal degeneration. However, more work
is needed to determine the mechanism of Rin activation in traumatic axonal injury
including how the interaction between Rin and DLK may be involved in prodegenerative pathway.

Copyright © Megan D. Pannell 2017

	
  

106	
  

CHAPTER 5

A Role for the Rin GTPase in Cytokine Production and Neuroinflammation
Introduction
Neuroinflammation is a major pathological component of secondary injury
cascades following TBI (Karve, Taylor et al. 2016). Within minutes of trauma, the
injured brain elicits a robust inflammatory response fundamental to wound repair
and regeneration (Gurtner, Werner et al. 2008, Woodcock and MorgantiKossmann 2013). Resident astrocytes and microglia predominate in the brain’s
innate response to injury, not only through the secretion of inflammatory factors,
but also by forming a physical barrier around the site of injury (glial scar), and
allowing for the phagocytosis of cellular debris and recognition of foreign
antigens (Morganti-Kossmann, Satgunaseelan et al. 2007, Hernandez-Ontiveros,
Tajiri et al. 2013, Karve, Taylor et al. 2016).
Microglia, the resident immune cells of the CNS, constantly survey the
brain microenvironment (Nimmerjahn, Kirchhoff et al. 2005). Following injury,
they rapidly respond to damage associated molecular patterns (DAMPs),
chemoattractants, and various forms of cell debris (Davalos, Grutzendler et al.
2005, Nimmerjahn, Kirchhoff et al. 2005) through pattern recognition receptors
on their cell surface	
  (Chen and Nunez 2010). Receptor activation leads to the

secretion of cytokines that can either initiate an inflammatory response (for
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example, IL-1β and TNF-α) or a wound healing response (for example, IL-10)
(Morganti-Kossmann, Satgunaseelan et al. 2007, Chen and Nunez 2010).
Stress activated protein kinases, such as p38, respond to various cellular
and environmental stimuli, including UV irradiation, hypoxia, oxidative stress, and
pro-inflammatory cytokines (Tibbles and Woodgett 1999). The p38 MAPK
cascade has been demonstrated to serve as a crucial component for the
production of IL-1β and TNF-α and neuronal degeneration in vitro (Bachstetter,
Xing et al. 2011, Xing, Bachstetter et al. 2011) and in the regulation of microglial
morphological activation in vivo (Bachstetter, Rowe et al. 2013). Although p38
stimulation has been extensively studied in stress response, it has also been
demonstrated to play fundamental roles in development, proliferation, survival,
and differentiation (Martin-Blanco 2000, Nebreda and Porras 2000). Following
brain injury, p38 activation is observed within minutes (Mori, Wang et al. 2002).
Numerous reports have shown that activation of the p38 MAPK cascade is
associated with neuronal death caused by numerous neurotoxic reagents
including excessive and unregulated neurotransmitter release (excitotoxicity)
(Cao, Semenova et al. 2004, Semenova, Maki-Hokkonen et al. 2007, ChaparroHuerta, Flores-Soto et al. 2008), nerve injury (Wittmack, Rush et al. 2005), and
ischemia (Wang, Xu et al. 2002, Guo and Bhat 2007). Because p38 plays an
essential signaling role in injured neurons and work from our lab has previously
demonstrated that the Rin GTPase lies upstream of p38 following nerve growth
factor stimulation (Shi, Han et al. 2005), we were interested in determining if Rin
loss would alter post-injury inflammation.
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Results
Rin loss suppresses the acute pro-inflammatory response following CHI
To assess the role of Rin loss on inflammatory signaling and cytokine
production, we used a diffuse closed head injury model (CHI) that generates
traumatic axonal injury without causing contusion or tissue loss, but still induces
robust astrocyte and microglial activation (Kelley, Farkas et al. 2006, Kelley,
Lifshitz et al. 2007, Cao, Thomas et al. 2012). Although CHI induces mild
leakage of the blood brain barrier, the lack of a necrotic core limits the infiltration
of circulating immune cells (Kelley, Lifshitz et al. 2007) so that the majority of the
inflammatory responses observed come from resident glial cell populations within
the brain.
Inflammation is central to brain repair following injury. Normally, cytokine
production increases between 6 and 24 hrs following diffuse head injury,
contributing to glial activation and debris clearance, then subsequently decreases
by 7d after injury (Lloyd, Somera-Molina et al. 2008, Bachstetter, Rowe et al.
2013). However, inflammation that is excessive or prolonged can result in
neuronal dysfunction and neurological deficits by contributing to infection,
edema, or generation of reactive oxygen species (Lloyd, Somera-Molina et al.
2008).
We assessed cytokine production acutely (9 hr) following diffuse head
injury. Wild-type animals displayed significant elevation of the pro-inflammatory
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cytokines, IL-1β (285% increase compared to sham controls, Figure 5.1A) and
TNF-α (39% increase compared to sham controls, Figure 5.1C), within the
neocortex. Levels of the pro-inflammatory cytokine, IL-6 (Figure 5.1B), were also
elevated following CHI, but did not reach statistical significance. Although Rin-/animals also displayed elevation of IL-1β (91% increase compared to shaminjured controls, Figure 5.1A), its production was significantly blunted compared
to wild-type injured mice. Levels of IL-6 (Figure 5.1B) and TNF-α (Figure 5.1C)
also trended upwards, however were not statistically different from sham-injured
controls. Although Rin loss did not significantly blunt TNF-α production, there
was a clear downward trend in Rin-/- injured mice compared to wild-type injured
mice. Levels of IL-10, an anti-inflammatory cytokine, were also measured acutely
following injury, and were unchanged in wild-type injured mice compared to
controls (Figure 5.1D). Rin-/- mice, however, displayed significantly elevated IL10 (69% increase compared to sham-injured controls, Figure 5.1D). No
significant differences were observed between wild-type and Rin-/- sham animals
at any time point indicating that global Rin loss does not alter baseline cytokine
production (Figure 5.1).
By 7 d post-CHI, IL-6 and TNF-α cytokine production in wild-type mice had
returned to baseline (sham-injured) levels. However, IL-1β production in wild-type
mice remained elevated at 7 d following CHI (Figure 5.1A-C). Levels of IL-1β
and TNF-α remained significantly elevated 7 d following CHI in Rin null mice
(90% and 68% increase, respectively, Figure 5.1A, C) suggesting the possibility
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of a diminished, but prolonged, inflammatory response in the absence of Rin.
Both IL-6 and IL-10 production in Rin-/- injured mice were equivalent to shamoperated controls by 7 d post-CHI (Figure 5.1B, D). Collectively, these data
suggest a function for Rin in the control of cytokine production in the neocortex
following diffuse head injury.
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Figure 5.1 Rin loss alters cytokine production following diffuse brain injury.
Protein levels of IL-1β (A), IL-6 (B), TNF-α (C), and IL-10 (D) in the neocortex
were measured by MSD multiplex immunoassay 9hr and 7d following CHI.
Acutely following injury, Rin loss lead to a blunting of the pro-inflammatory
cytokine IL-1β and decreased IL-6 and TNF-α although levels did not reach
significance. Anti-inflammatory cytokine, IL-10, production was enhanced after
CHI in Rin KO mice. At 7d Rin loss enhanced IL-1β and TNF-α whereas levels of
IL-10 and IL-6 had returned to baseline. Data are expressed as mean ± SEM;
n=9-11; One-way ANOVA followed by Turkey-Kramer post hoc test *p<0.05,
**p<0.01, ***p<0.001. IL-1β was log transformed prior to analysis to adjust for
normality.
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Astrocyte activation unchanged by Rin loss
Since we determined that Rin loss blunted, but prolonged, acute proinflammatory, IL-1β, cytokine production following CHI (Figure 5.1A) we next
asked whether glial activation was altered downstream of diffuse TBI. Following
trauma, astrocytes become activated; this process of astrogliosis is characterized
by cellular proliferation and hypertrophy (increased expression of glial fibrillary
acidic protein (GFAP), elongation of cellular processes, and cytoplasmic
enlargement) (Saatman, Feeko et al. 2006, Bardehle, Kruger et al. 2013, Burda,
Bernstein et al. 2016). To this end, we performed IHC for GFAP, a marker of
astrocytes, to analyze changes in astrogliosis in the absence of Rin. At baseline,
GFAP is expressed at low levels within the mouse cortex as represented in the
sham control micrographs of Figure 5.2A. At 9 hr post-injury, GFAP expression
was not significantly increased from sham-injured controls. However, by 7 d
following injury, both wild-type and Rin null mice displayed an increase in the
expression of GFAP within the neocortex indicating injury-induced astrocyte
activation (Figure 5.2A). Quantification of GFAP staining in the neocortex
showed no discernable differences in astrocyte activation between sham and
injured animals 9 hr post-CHI, regardless of genotype (Figure 5.2B). However,
by 7 d following injury, GFAP was robustly increased in both wild-type (443%
increase compared to sham controls) and Rin-/- mice (155% increase compared
to sham controls). Although there was a clear trend towards blunted astrogliosis
in Rin-/- mice, no significant difference was observed between wild-type CHI and
Rin-/- CHI cohorts (p=0.578, one-way ANOVA followed by Turkey-Kramer post-
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hoc test) (Figure 5.2B). These data suggest that astrogliosis remains intact
following diffuse head injury in the absence of Rin expression.
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Figure 5.2. Astrogliosis in Rin null mice remains intact following diffuse
head injury. A. Representative images of GFAP immuno-staining 9 hr and 7 d
post-CHI indicate that astrocyte activation occurs 7 d following injury regardless
of genotype. B. Quantification of GFAP staining shows a significant increase in
astrogliosis in wild-type mice 7 d post-injury and no significant difference was
observed between WT CHI and Rin KO CHI cohorts suggesting Rin loss does
not affect injury-induced astrocyte activation. Data are expressed as mean ±
SEM as a percent of wild-type sham-injured mice; n=9-11; one-way ANOVA
followed by Turkey-Kramer post hoc test **p<0.01.
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Microglial activation following injury unaltered by Rin loss
To determine whether changes in mircoglia activation could account for
the diminishment in pro-inflammatory cytokine production observed in Rin null
mice, we performed IHC for CD-45. CD-45 is a transmembrane protein tyrosine
phosphatase expressed at low levels on resident microglia, however, its
expression has been shown to increase acutely following traumatic injury
(Sedgwick, Schwender et al. 1991, Bachstetter, Rowe et al. 2013). Due to high
background, CD-45 IHC staining was scored on a 7-point scale for CD-45
immuno-positive cells within the cortex, hippocampus, and corpus callosum by
an experimenter blinded to genotype and treatment. Both wild-type and Rin-/mice displayed increased staining of CD-45 expression 9 hr following CHI
(Figure 5.3A, B). CD-45 is also expressed on leukocytes, or circulating blood
cells, that can infiltrate following trauma due to breakdown of the blood brain
barrier. These cells can be morphologically distinguished from microglia due to
their lack of arborization. Quantification of infiltrating leukocytes showed no
differences between cohorts (Figure 5.3C). Together these data suggest that Rin
loss does not alter microglial activation following diffuse head injury.
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Figure 5.3. Rin null mice display normal microglial activation following CHI
A. Representative images of CD-45 immune-staining 9hr indicate that microglial
activation is intact in Rin null mice. B. Quantification of CD45 staining on a 7point scale displays increased microgliosis in wild-type mice 9hr post-injury and
no significant difference was observed between wild-type CHI and RinKO CHI
cohorts suggesting Rin loss does not affect injury-induced microglial activation.
Data are expressed as mean ± SEM; one-way ANOVA followed by TurkeyKramer post hoc test; n=9-11.

	
  

119	
  

Axonal protection afforded by Rin loss
Because the changes observed in cytokine profiles following injury could
not be explained by changes in glial activation, we evaluated injury at the level of
the neuron. Diffuse models of TBI do not result in high levels of cell death and
tissue loss; however, does lead to traumatic axonal injury throughout the
mediodorsal neocortex (Kelley, Farkas et al. 2006, Kelley, Lifshitz et al. 2007,
Cao, Thomas et al. 2012). Beta amyloid precursor protein (β−APP) is a common
marker for traumatic axonal injury following trauma as it accumulates in axonal
bulbs or swellings within hours following injury, due to disruption of axonal
transport (Roberts, Gentleman et al. 1994, Suehiro and Povlishock 2001, Smith,
Uryu et al. 2003).
To evaluate whether Rin loss diminishes axonal injury, we performed IHC
for β−APP 9 hr following CHI. Both wild-type and Rin-/- sham-injured controls
displayed minimal accumulation of β−APP in axonal swellings (wild-type, 0.07
punta/mm2; Rin-/-, 0.41 punta/mm2, Figure 5.4). As expected, there was an
accumulation of aberrant β−APP localization to axonal swellings within the
neocortex of wild-type mice following injury (3.78 punta/mm2). However, Rin loss
resulted in significantly diminished axonal β−APP staining following CHI (0.90
punta/mm2, Figure 5.4). These data suggest axonal protection following CHI in
the absence of Rin.
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Figure 5.4. Acute axonal injury blunted following CHI in the absence of Rin.
A. Images of neocortical beta-amyloid precursor protein (β−APP) 9 hr following
closed head injury in wild-type and Rin-/- animals. Arrows indicate examples of
positive β−APP staining. Images were taken at the injury epicenter where β−APP
accumulation was highest. B. Quantification of β−APP in the neocortex following
injury indicates that Rin loss diminishes axonal swellings suggesting axonal
protection. Data are expressed as mean ± SEM; n=9-11; one-way ANOVA
followed by Turkey-Kramer post hoc test **p<0.01.
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Analysis of the impact of Rin deficiency on post-CHI cognitive performance
Decreased pro-inflammatory cytokine production and axonal injury have
been associated with improved behavioral outcomes in experimental models of
TBI (Bachstetter, Rowe et al. 2013, Bachstetter, Webster et al. 2015). To
determine whether Rin loss could improve behavioral outcomes following CHI,
we performed radial arm water maze (RAWM), a spatial learning task (Alamed,
Wilcock et al. 2006) with observable deficits up to 2 weeks following CHI
(Webster, Van Eldik et al. 2015). Overall, Rin loss had no significant effect on
RAWM performance (Figure 5.5A, two-way repeated measure ANOVA);
however, when teased apart, clear trends were noted. While wild-type mice
displayed significant spatial learning deficits following CHI (Figure 5.5B), Rin-/sham and Rin-/- injured mice performed equivalently (Figure 5.5C). Injured wildtype and Rin-/- cohorts were found to perform equivalently (Figure 5.5D).
Importantly, Rin-/- mice tended to have more errors than wild-type mice in the
absence of injury (Figure 5.5E), suggesting that Rin loss results in a baseline
defect in this assay (although this trend does not reach statistical significance). It
is promising that Rin-/- sham and Rin-/- injured mice performed similarly in the
task. However, the intrinsic performance differences at baseline between wildtype and Rin-/- mice, combined with the modest increase in RAWM errors
following CHI (~1 additional error following injury), do not permit definitive
conclusions regarding cognitive sparing at this time.
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Figure 5.5. Behavioral effects of Rin loss on CHI behavioral outcomes.
Radial arm water maze assessed 14 d following CHI revealed (A) no significant
alterations in performance based on genotype (B) a diminishment in cognitive
performance of WT mice (C) no alteration between Rin-/- sham and Rin-/- CHI
(D) no alteration between WT CHI and Rin-/- CHI (E) a clear trend towards
decreased cognitive performance in Rin-/- sham animals. All data are expressed
as mean ± SEM; n=9-11. Panel A was analyzed via a two-way repeated
measures ANOVA whereas panels B-E were analyzed by one-way repeated
measures ANOVAs.
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Discussion
In the present study, we have identified a potential role for Rin GTPase in
the initiation of neuroinflammation following diffuse brain injury. We demonstrated
that Rin loss blunts acute production of pro-inflammatory IL-1β at 9 hr post-CHI,
and, although it does not reach significance, a similar trend is observed in TNF-α
production (Figure 5.1 A, C). Moreover, the absence of Rin increased the levels
of anti-inflammatory IL-10 acutely following injury (Figure 5.1D). Interestingly,
although acute IL-1β production was blunted in Rin null injured mice, there
appeared to be prolonged pro-inflammatory response, as the levels of IL-1β had
not returned to baseline by 7 d post-CHI (Figure 5.1A). Although glial
populations respond to damage through secretion of cytokines (MorgantiKossmann, Satgunaseelan et al. 2007, Chen and Nunez 2010) we were unable
to discern any considerable difference in the degree of astrocyte or microglial
activation between wild-type and Rin-/- injured animals. However, we did find that
Rin loss resulted in significantly diminished axonal accumulation of β-APP
staining following CHI, suggesting that axonal injury was reduced, consistent with
previous data following optic nerve injury (Chapter 4). Together these data
suggest that Rin contributes to the regulation of post-CHI cytokine production,
and axonal injury. However, due to the baseline differences in behavior between
wild-type and Rin-/- sham-injured mice, it is currently unclear if this has any effect
on behavioral outcomes following diffuse head injury.
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Although microglia are a major source of injury-related cytokine release
(Hanisch 2002), other cell types, including astrocytes, have also been
demonstrated to produce inflammatory mediators following stimulation (Kan, van
der Hel et al. 2012, Choi, Lee et al. 2014). Neurons, although generally thought
of as a cytokine target, express Toll-like receptors and can both sense and
mount inflammatory responses (Lafon, Megret et al. 2006) including the
production of IL-1β, IL-10, TNF-α, in response to diverse stimuli (Freidin, Bennett
et al. 1992, Yamamoto, Yamashita et al. 2011, Lim, Lu et al. 2016). In our
current study, Rin deficiency altered cytokine production; however, preliminary
findings found no evidence that glial activation was altered. These data would
suggest that cytokine release from these populations was equivalent in wild-type
and Rin null mice. These results are in agreement with lack of endogenous
expression of Rin in glial populations (Cahoy, Emery et al. 2008), however,
isolation and stimulation of astrocyte and microglial cultures would be required to
conclusively confirm that Rin function does not play a role in this cell types.
Instead, differences in axonal injury following trauma may indicate that the
altered cytokine profiles may result from decreased neuronal cytokine release.
Given that these studies were conducted in a whole-body knock-out mouse, it is
not possible to test this hypothesis in vivo. Regardless, the notion of cytokine
differences post-injury being neuronally based are in line with previous studies
indicating that Rin expression is limited to neurons and warrants further
investigation (Shao, Kadono-Okuda et al. 1999, Lafon, Megret et al. 2006,
Cahoy, Emery et al. 2008, Sharma, Schmitt et al. 2015). While it is unlikely, due
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to the nature of the injury, that the differences in cytokine profiles is the result of
infiltrating immune cells of the PNS, we cannot completely rule out this
possibility.
Previous studies from the lab have demonstrated that Rin lies upstream of
p38 stress-kinase signaling (Shi, Han et al. 2005), a pathway that has been
demonstrated to be upregulated following brain and ischemic injuries (Sugino,
Nozaki et al. 2000, Nozaki, Nishimura et al. 2001, Mori, Wang et al. 2002,
Donninger, Calvisi et al. 2015). Furthermore, microglial specific deletion of p38α
leads to cognitive behavioral improvement following diffuse head injury
(Bachstetter, Rowe et al. 2013). To date, our post-CHI behavioral data is
inconclusive regarding the important issue of whether Rin loss provides spatial
learning protection following diffuse brain injury, as our results indicate that there
is a baseline behavioral deficit in Rin null animals that could be due to long-term
Rin deletion or a difference in genetic background (Rin-/- mice were generated by
pronuclear microinjection of 129SvEv ES cells into C57BL6/N blastocysts).
Although we did not see a significant behavioral sparing, it is promising that Rin-/sham and Rin-/- CHI mice displayed no behavioral differences using RAWM
analysis, and it remains to be determined whether Rin loss provides functional
sparing. Plans are underway to resolve this issue using two approaches. First,
we have just completed ten generations of backcrossing the Rin null genetic
deletion line into C57BL6 mice to generate a defined genetic background. In
addition, we are engineering a Rin conditional knock-out mouse line that would
permit cell-type specific Rin deletion.
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In summary, the data in this chapter suggests a role for Rin in the
regulation of cytokine production following CHI. We postulate that the differences
observed are the result of neuronal specific Rin actions, not only because all
available evidence indicates that Rin is expressed solely in neurons, but also
because of the significant reduction in axonal injury found in Rin-/- mice following
diffuse head injury. However, more research is needed to define the role for Rin
in the regulation of neuronal-specific inflammatory signaling.
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CHAPTER SIX

Discussion

The studies in this dissertation were performed with the goal of identifying
the physiological function of neuronally expressed Rin GTPase. To address this
question, we used a mouse line bearing a genetic deletion of the endogenous
Rin (RIT2) gene generated through gene trap insertion (Figure 3.1). Previous
research in the lab indicated that Rin signaled downstream of growth factor
stimulation (Shi and Andres 2005) and demonstrated that the closely related
protein Rit functioned in post-trauma induction of neurogenesis (Cai, Carlson et
al. 2012). Therefore, we implemented traumatic injury models to test the ability of
Rin to improve neuronal survival and enhance cognitive outcomes following CNS
injury. Using this novel knockout model, we have begun to characterize the
genetic deletion of Rin and implicate a functional role for Rin in three major
components of CNS trauma: neuronal death, axonal degeneration, and
neuroinflammation. In doing so, we have not only demonstrated functionally
divergent roles for Rin and Rit GTPases, but also established Rin deficiency as
neuroprotective- clearly identifing roles for Rin in the regulation of neuronal cell
loss and axonal degeneration following brain injury. The data presented within
this dissertation suggests that Rin may be a viable therapeutic target following
TBI.
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Rin and Rit GTPase display functional specificity
Due to conservation of effector domain sequences and downstream
effectors, it was believed that Rin would function similarly to the closely related
GTPase, Rit, to regulate proliferation and survival (Reuther and Der 2000).
However, early findings within our laboratory suggested that the two GTPases
acted independently in vitro, with Rin expression resulting in decreased cell
viability in cell culture models (data not shown). To further study Rit and Rin
regulation, we moved our studies to in vivo mouse models. Studies conducted by
Dr. Weiakng Cai, a previous graduate student in the lab, found that Rit deficiency
increased neurodegeneration within the hippocampus following CCI (Cai,
Carlson et al. 2012). Shown here, Rin loss revealed a strikingly distinct role
following CCI injury model, increasing neuronal survival (Figure 3.3). Further,
Rin loss had no effect on post-traumatic neurogenesis (Figures 3.4, 3.5, 3.6),
although Rit has been demonstrated to be a key contributor in neurogenesis and
proliferation of neural stem cells (Cai, Carlson et al. 2012, Mir, Cai et al. 2017,
Mir, Cai et al. 2017). Together, these data support distinct physiological functions
for these two closely related Ras family members.
Although functional specificity had not been demonstrated in vivo prior to
this work, there were several lines of evidence that indicated the divergence
properties of Rin and Rit GTPase. First, unlike other members of the Ras family,
Rin is unable to transform NIH-3T3 cells (Rusyn, Reynolds et al. 2000). Second,
endogenous Rin expression was unable to complement Rit loss (Cai, Rudolph et
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al. 2011). And finally, Rin and Rit have been associated with distinct pathological
outcomes. Genetic GWAS studies have linked the loss of heterozygosity, or
chromosomal events that result in RIT2 gene loss or silencing, to predominantly
neuropsychological disorders, including autism, schizophrenia and Parkinson’s
disease (Glessner, Reilly et al. 2010, Pankratz, Beecham et al. 2012,
Emamalizadeh, Movafagh et al. 2014, Liu, Guo et al. 2015, Nie, Feng et al. 2015,
Wang, Gong et al. 2015, Zhang, Niu et al. 2015, Liu, Shimada et al. 2016, Foo,
Tan et al. 2017, Hamedani, Gharesouran et al. 2017, Li, Zhang et al. 2017). In
contrast, mutations that lead to the activation of Rit has been connected to both
the developmental disorder, Noonan Syndrome, in the case of germinal mutation,
and lung cancer and leukemia if the mutation is somatic (Berger, Imielinski et al.
2014, Chen, Yin et al. 2014, Xu, Sun et al. 2015, Cave, Caye et al. 2016,
Koenighofer, Hung et al. 2016). Together these lines of evidence further
suggested that Rin and Rit, despite their biochemical similarities, were
functionally unique.
An interesting question that remains to be answered is how the functional
specificity between Rin and Rit GTPase is achieved. A similar conundrum was
faced in regards to the three extremely well conserved founding members of the
Ras family (H-Ras, K-Ras and N-Ras), which share approximately 80% primary
sequence identity. Several broad themes underlying their functional separation
have been described (Castellano and Santos 2011). These include 1) differential
patterns of tissue and developmental expression, 2)	
  distinct specificities to

different GAPs or GEFs, and 3) different intracellular pathways of processing and
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membrane localization (Castellano and Santos 2011). It is conceivable that these
characteristics also apply to the Rit subfamily and are discussed below.
Expression differences between Rin and Rit have already been
demonstrated broadly across tissues and development. Rit is expressed
ubiquitously throughout the organism and throughout development, whereas Rin
expression is limited to the CNS and is first detected late during mouse
embryonic development (first appearing around e15 in the mouse brain) (Lee,
Della et al. 1996, Spencer, Shao et al. 2002, Cahoy, Emery et al. 2008, Sharma,
Schmitt et al. 2015). The literature indicates that both Rin and Rit are expressed
within neurons (Lee, Della et al. 1996, Shao, Kadono-Okuda et al. 1999), and our
lab has demonstrated that the two proteins are activated by similar stimuli (Shi,
Cai et al. 2013). So how is it determined which signal dominates? In K-Ras
functionality can be determined through expression differences following
stimulation. For example, it has been demonstrated that the levels of K-Ras4B
are higher under physiological conditions, whereas K-Ras4A expression is
induced during differentiation of pluripotent embryonic stem cells	
  (Pells, Divjak et

al. 1997). However, these forms of K-Ras are splice variants (Barbacid 1987)

and alternatively spliced isoforms of Rit and Rin have not been described. It is
more likely that differences in functionality are derived through distinct specificity
of GEF and GAP proteins or subcellular localization.
GEFs and GAPs regulate the activation states of small GTPases,
therefore, controlling their intracellular signaling pathways and cellular roles	
  (Bos,
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Rehmann et al. 2007). GEFs are direct activators of the Ras superfamily of
GTPases; thereby, each stimulus that results in Ras activation requires GEF
regulation	
  (Quilliam, Khosravi-Far et al. 1995, Bernards and Settleman 2007).

Furthermore, these proteins display substrate specificity in activating specific
families of GTPases. For example, son of sevenless (SOS) preferentially

activates Ras and Rac family members, but not Rap proteins	
  (Nimnual and BarSagi 2002). Ras GAP proteins are required to stimulate GTP hydrolysis, ending

signaling on a physiological time scale (Bernards and Settleman 2005). To date,
few studies have accessed Rit subfamily regulatory proteins. However,
association between Rin and SOS has been shown through coimmunoprecipitation (Hoshino and Nakamura 2002). It has also been
demonstrated that expression of the Ras specific GAP proteins, SynGAP and
GAP1, can significantly decrease the concentration of GTP bound Rin; however,
the Rap specific GAP, Rap1-GAP had no effect (Hoshino and Nakamura 2002).
Similar to Rin, GTP bound Rit levels were elevated following expression of the
Ras specific GEFs SOS and GRF (Spencer, Shao et al. 2002). With the data
currently available it is impossible to determine the degree of regulatory overlap
between Rin and Rit. However, given their apparent functional distinctions, this is
a critical issue to generating greater understanding Rin and Rit signaling that
requires further study.
The subcellular distribution of small GTPases provides additional control
of activation and function by allowing for association with and activation of local
effectors in distinct cellular compartments (Castellano and Santos 2011). In this

	
  

132	
  

way, despite identical effector and regulatory domains, Ras isoforms display
functional specificity	
  (Chiu, Bivona et al. 2002). For example, plasma membrane
associated K-Ras enables transformation, whereas mitochondrial localized K-

Ras induces apoptosis (Bivona, Quatela et al. 2006). Unlike other Ras family
members that undergo post-translational lipidation to ensure membrane tethering
(Lowy and Willumsen 1993, Reuther and Der 2000), the Rit subfamily lacks
canonical lipidation sequences (Shi, Cai et al. 2013). Indeed, currently there is no
data available to indicate that they undergo lipid modification of any sort. Instead
Rit subfamily proteins are localized through interactions between their extended
polybasic C-terminus and charged PI(3,4,5)P3 and PI(4,5)P2 lipids on the plasma
membrane (Heo, Inoue et al. 2006). To date the subcellular localization of Rin
and Rit have not been extensively characterized. However, immunostaining for
Rit in hippocampal neurons shows that Rit is localized not only in the cell body,
but also the dendritic arbors and axonal shaft (Lein, Guo et al. 2007). Although
subcellular localization has not been characterized for Rin, herein, we describe a
novel role for Rin in the regulation of trauma-induced cell death (Figure 3.3, 3.7)
and axonal injury (Chapter 4 and Figure 5.4), suggesting that Rin signaling
affects processes in both the cell body and axon. Further characterization of the
subcellular localization could provide valuable insight into the function and
regulation of the Rit subfamily of GTPases.
Does Rin signaling contribute to neuronal death?
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The studies presented in this dissertation indicate that Rin loss is
neuroprotective, leading to the hypothesis that Rin signaling may contribute to
neuronal loss following trauma. If this hypothesis holds, expression of a
constitutively active Rin mutation (RinQ78L) would diminish cell viability or initiate
cell death in the absence of additional stimulation. Because Rin expression is
limited to neurons, the best in vitro model system for these experiments would be
primary neuronal cultures to ensure that Rin specific effectors are endogenously
expressed. Furthermore, it might be important to use long-term neuronal
cultures, to ensure they mature, as Rin loss does not appear to impact immature
neuron survival in the hippocampus following contusive injury (Figure 3.4). Given
our current data, it would be interesting to examine Rin expression in immature
neurons and progenitor cell populations within the hippocampus. For the simplest
explanation of why Rin loss has no apparent effect on these populations
following trauma (Figures 3.4, 3.5, 3.6) is because Rin protein is not expressed
in these early developmental cell types. Because Rin is not expressed at early
developmental time points	
  (Lee, Della et al. 1996), this remains a conceivable

hypothesis.

Although Rin is expressed in both cortical and hippocampal neuronal
populations (Cahoy, Emery et al. 2008), our data suggest that Rin loss
selectively protects hippocampal (Figure 3.3, 3.7), but not cortical neurons
(Figure 3.2) following focal brain injury. Transferring studies into primary neurons
would allow determination of whether selective protection is an effect of the
hippocampal neuronal population itself or possibly due to differences in the
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nature of stimuli needed to activate Rin (assuming that Rin activation initiates cell
loss). Comparison of neuronal death and dendrite degeneration in cortical and
hippocampal neurons generated from wild-type and Rin-/- mice would provide
valuable insight in to the protective nature of Rin loss following stimulation with
various experimental models of secondary injury. Neurons could be treated with
L-glutamate to mimic excitotoxicity (Choi, Maulucci-Gedde et al. 1987), sodium
nitroprusside, a nitric oxide donor, an experimental model for reactive oxygen
species	
  (Dawson, Dawson et al. 1993), and oxygen-glucose deprivation to
induce hypoxia ischemia (Kaku, Goldberg et al. 1991). If Rin loss leads to

selective protection of hippocampal neurons, then wild-type and Rin-/- cortical
neurons should display the same degree of cell loss and viability while Rin-/hippocampal neurons would display increased viability compared to wild-type
hippocampal neurons. However, if the differences observed in the hippocampus
and cortex following CCI were due to the type of stimulus, then we would expect
differential protection in the two populations based on the experimental injury
model.
The role of Rin in axonal degeneration
We have demonstrated in two separate injury models that Rin loss
decreases axonal pathology. Following optic nerve stretch, axonal damage was
equivalent acutely following injury (Figure 4.1); however, Rin loss significantly
blunted the progression of degeneration 7 d following stretch injury (Figure 4.2).
Furthermore, Rin loss was shown to diminish axonal damage in the cortex
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acutely following diffuse closed head injury (Figure 5.4). Although these injury
paradigms cannot be directly compared, axonal protection in both models,
strongly implicates Rin signaling in the progression of axonal degeneration.
Therefore, it will be interesting to assess the dependence of Rin signaling in the
activation of known degenerative pathways.
Rin was shown to associate with DLK (Figure 4.3), a known regulator of
axonal degeneration and cell death (Tedeschi and Bradke 2013). Levels of DLK
have been determined to increase following injuries to the optic nerve and dorsal
root ganglia (Watkins, Wang et al. 2013, Welsbie, Yang et al. 2013). Although
DLK has been shown to lie upstream of both p38 and JNK MAPKs, the activation
of JNK has been demonstrated as necessary to commit axons to a degenerative
fate following injury, as its pharmacological inhibition is sufficient to blunt axonal
fragmentation (Miller, Press et al. 2009). Furthermore, trauma-induced
heightened DLK expression has been demonstrated to lead to subsequent
increased phosphorylation and activation of JNK and c-Jun (Chen, Rzhetskaya et
al. 2008, Ghosh, Wang et al. 2011, Watkins, Wang et al. 2013, Welsbie, Yang et
al. 2013) (Figure 6.1). These studies from the literature, along with the DLK-Rin
interaction, and the ability of Rin loss decrease degeneration provoked the
hypothesis that Rin signals upstream of the DLK signaling cascades. If the
hypothesis holds, Rin activation should increase the ability of DLK to activate
JNK and c-Jun, as indicated by increased phosphorylation, and its loss diminish
these effects. Strikingly, preliminary data generated by Binoy Joseph in the
Saatman laboratory suggests that Rin loss blunts activation of c-Jun within the
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retinal ganglion cells following optic stretch injury (data not shown). Further
studies are needed to analyze the effects of Rin loss on JNK activation acutely
following optic stretch; however, these data provide strong initial support of Rin
regulating axonal degeneration upstream of the JNK MAPK cascade.
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Figure 6.1. Does the trauma-induced DLK-JNK MAPK cascade include Rin
GTPase activation? Axonal trauma induces activation of DLK. Once activated,
DLK signals to JNK through MKK4/7. JNK has many substrates in the cell
including c-Jun and SCG10. Activation of the transcription factor c-Jun has been
associated with axonal degradation and cell death. JNK can also directly
phosphorylate axonal SCG10 targeting it for degradation; loss of SCG10
precedes axonal degradation. The ability of Rin to interact with DLK, diminish cJun activation following stretch injury, and blunt axonal degradation suggests that
Rin may regulate the DLK-JNK cascade following trauma.
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Because Rin loss decreases activation of the JNK substrate, c-Jun, it
would be interesting to look at other JNK substrates associated with axonal
degeneration. SCG10 was identified as an important JNK substrate within the
axon and its levels have been correlated with axonal fragmentation (Shin, Miller
et al. 2012). Phosphorylation of SCG10 by JNK targets the protein for
degradation (Figure 6.1). In a healthy neuron, SCG10 is rapidly replaced in the
axon through anterograde transport; however, following trauma, transport is
disrupted and SCG10 expression in the axon is lost (Shin, Miller et al. 2012).
Diminished levels of axonal SCG10 have been correlated with axonal
fragmentation of cultured neurons of both the PNS and CNS and, furthermore,
silencing of SCG10 through short hairpin RNA was demonstrated to increase the
rate of axonal fragmentation (Shin, Miller et al. 2012). Herein, we observed
diminished axonal pathology following both optic nerve stretch (Figure 4.2) and
diffuse head injury (Figure 5.4) in Rin null mice. Blunted axonal degradation
would suggest lessened neurofilament fragmentation in which case, levels of
SCG10 in the axon would be maintained. Rin loss could decrease JNK
activation, thereby lessening SCG10 phosphorylation and turnover; either
scenario would lead to maintained axonal SCG10 concentrations. Although
further investigation is needed, the maintenance of axonal SCG10 concentrations
could be another mechanism through which Rin loss blunts axonal pathology
following axonal injury.
A more in-depth analysis of Rin in Wallerian degeneration
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The literature indicates that the absence of DLK protects distal axons from
Wallerian degeneration (Miller, Press et al. 2009, Yang, Wu et al. 2015), which
led us to examine the breakdown of distal axons following optic nerve transection
in Rin null mice. Although preliminary, our initial studies do not suggest a role for
Rin in Wallerian degeneration as the extent of axonal degeneration showed no
discernable difference at 24 hr (Figure 4.7) or 7d (Figure 4.8) following
transection. However, a more extensive analysis of more acute time points
following injury is needed to confirm that Rin loss has no effect on Wallerian
degeneration. Given the degree of axonal protection out to 7 d following optic
nerve stretch, we decided to analyze Wallerian degeneration at the same
endpoints hypothesizing that loss would be equally protective in both optic nerve
stretch and transection. However, the pathway in which Rin signals through
would ultimately determine the timeframe of axonal protection. For example, DLK
deletion only delays axonal clearance for hours in mouse models and a couple
days in Drosophila (Miller, Press et al. 2009). Simultaneous silencing of the three
known JNK MAPKKK proteins (DLK, MKK2, and MEKK4) upstream of axonal
degeneration only effectively diminished distal axon fragmentation for 6 d
following a milder optic crush injury (Yang, Wu et al. 2015). If Rin loss results in
delayed axonal degeneration at a shorter time period, for instance hours
following transection as would be expected by inhibition of DLK, we could have
missed the effect of Rin deficiency on Wallerian degeneration in our preliminary
optic transection studies.
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It is also possible that the methods we used to analyze Wallerian
degeneration did not give a clear depiction of axonal breakdown. Our current
Wallerian data was generated through immunostaining of non-phosphorylated
neurofilament (SMI-32) along the optic nerve following transection; however, this
method has several limitations. Immunostaining did not allow us to track
degeneration along a single severed axon, therefore we were unable to
determine the percentage of axons undergoing Wallerian degeneration at a
select time point and the percentage of axons that were spared. A more
appropriate model would entail the use of Thy1-YFP mice, which express yellow
fluorescent protein (YFP) at high levels within motor and sensory neurons
including those of the retinal ganglion cell layer (Beirowski, Berek et al. 2004). In
this model, YFP expression is randomly distributed in approximately 3% of these
neuronal populations, resulting in sparse YPF labeling throughout the cell bodies
and axons of both the central and peripheral nervous systems (Beirowski, Berek
et al. 2004). The restricted axonal labeling in Thy1-YFP mice permits quantitative
and qualitative analysis of Wallerian degeneration because axonal collapse of a
single cell can be visualized as fragmentation of the YPF labeled axons
(Beirowski, Berek et al. 2004). Crossing Thy-1 YFP mice with our Rin knockout
line would allow for a more thorough examination of the effects of Rin loss on
axonal breakdown following optic transection. Generation of Thy1-YFP mice in
our Rin-/- background have been generated in the lab (Figure 6.2) and will
provide a new perspective to analyze axonal breakdown.
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Figure 6.2. Thy-1 YFP mice will allow for tracing of axonal degeneration
along a single axon. The neurons of Thy-1 YFP mice contain sparse labeling of
YFP in neuronal cell bodies and axons. Axonal degeneration can thereby be
observed and quantified along a single axon or population of axons.
Representative confocal images of wild-type Thy1-YFP mouse brain hemisphere
(2X), optic nerve whole mount (2X), CA1 (20X), and dentate gyrus (20X).
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The combination of sparse labeling and more acute time intervals will give
a more accurate depiction of the role of Rin in Wallerian degeneration. A milder
optic crush injury may also be considered in order to slow axonal clearance and
prolong the window that protection can be observed. However, it is also possible
that Rin loss regulates neuronal cell death through DLK signaling, yet has no
effect on Wallerian degeneration.
Could Rin loss enhance axonal regeneration?
Herein, we did not investigate the possibility that Rin loss enhances
axonal regeneration following injury, although this would provide an alternative
explanation to the observed decreases in SMI-32 (Figure 4.2) and APP (Figure
5.4) immunostaining following stretch and CHI injury. The optic stretch model
does not lend itself to regeneration studies due to the diffuse nature of the injury
throughout the optic nerve. Previous literature, however, has demonstrated that
the mild head injury (CHI) model utilized in Chapter 5 causes traumatic axonal
injury that does not progress to cell death, instead axons show signs of
reorganization and repair within a week of injury (Singleton, Zhu et al. 2002,
Greer, McGinn et al. 2011, Greer, Povlishock et al. 2012). Although, electron
microscopy could be used to determine the extent of axonal reorganization
following CHI, it is not ideal due to the diffuse nature of the injury. Indeed, the
question would be best examined using optic nerve crush (Watkins, Wang et al.
2013) to provide a distinct point of injury and quantification of axonal sprouting
beyond the injury site.
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Rin expression in pheochromocytoma cells has previously been
demonstrated to activate members of the Rho family of GTPases including
RhoA, Cdc42, and Rac (Hoshino and Nakamura 2003) suggesting Rin may be
capable of modulating cytoskeletal dynamics upstream of Rho family GTPases in
neurons (Jaffe and Hall 2005). The RhoA/Rho kinase (ROCK) pathway is
involved in several CNS processes including both physiological responses
(dendrite development and axon extension) and pathological outcomes in CNS
injury, stroke, neurodegenerative disease (Fujita and Yamashita 2014). Following
injury activation of the RhoA/ROCK pathway has been associated with blunted
regenerative responses. Indeed, inhibition of RhoA has been demonstrated to
increase nerve regeneration following optic injury (Lehmann, Fournier et al. 1999,
Fischer, Petkova et al. 2004, Bertrand, Winton et al. 2005) (Figure 6.3). The
regenerative response associated with RhoA inhibition is believed to be
dependent on blunting the activation of ROCK, as its inhibition also leads to
improved regenerative responses in the CNS following trauma (Lingor, Teusch et
al. 2007, Lingor, Tonges et al. 2008). If Rin lies upstream of RhoA, then it is
possible that genetic deletion of Rin would also initiate improved nerve
regeneration following optic tract injuries though reduced RhoA signaling,
providing a novel molecular mechanism to explore the regenerative response in
Rin null animals.
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Figure 6.3. Does Rin activate RhoA following traumatic injury? Signaling
through RhoA/ROCK has been demonstrated to inhibit axonal regeneration
following injury. If Rin is capable of activating RhoA, then Rin deletion should
have similar affects as RhoA or ROCK inhibition and increase axonal
regeneration.
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Role for Rin in inflammatory responses
To assess the role of Rin in post-traumatic neuroinflammation, we utilized
a mild concussive injury that leads to a robust inflammatory response in the
absence of cell death (Kelley, Farkas et al. 2006, Kelley, Lifshitz et al. 2007, Cao,
Thomas et al. 2012). Despite reports of Rin expression being limited to neuronal
populations (Lee, Della et al. 1996, Spencer, Shao et al. 2002, Cahoy, Emery et
al. 2008, Sharma, Schmitt et al. 2015) we demonstrated that Rin null animals
displayed blunted pro-inflammatory and enhanced anti-inflammatory cytokine
production acutely following injury (Figure 5.1). This result is interesting given
that cytokine production is prominently carried out by glial populations
(Hernandez-Ontiveros, Tajiri et al. 2013, Karve, Taylor et al. 2016). However, in
line with neuronal expression of Rin, Rin-/- mice displayed no significant reduction
of astrogliosis or microgliosis following CHI (Figure 5.2, 5.3).
Although neurons are often thought to respond to cytokine signaling,
literature suggests that they can also produce cytokines in response to
stimulation (Freidin, Bennett et al. 1992, Yamamoto, Yamashita et al. 2011, Lim,
Lu et al. 2016). Because our previous work indicates decreased neuronal loss in
Rin null animals (Chapter 3), we are lead to believe that the changes of cytokine
profiles may result from diminished neuronal damage following injury. In order to
confirm that changes in cytokine production are the result of neuronal
populations we would need to culture primary neurons and measure cytokine
levels following stimulation with neurotoxic agents. Stimulation of in vitro primary
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neuronal cultures would allow us to monitor the effects of Rin loss without having
to take into consideration other CNS cell populations. If Rin signals upstream of
cytokine production in neurons, we should observe blunted production of IL-1β
and TNF-α following with L-glutamate, sodium nitroprusside, and oxygen-glucose
deprivation.
To date, Rin expression has not been identified outside of the CNS.
However, a more thorough examination of peripheral immune cells is needed to
rule out the possibility of Rin expression in infiltrating cell types, such as
macrophages of neutrophils. If Rin were expressed in non-resident immune cells,
it would provide a possible explanation for the changes we observed in cytokine
production acutely following CHI. To determine whether Rin is expressed in
macrophages and/or neutrophils, these cell populations would need to be
extracted and cultured from wild-type animals for qPCR analysis of Rin.
Furthermore, if Rin signaling is necessary for cytokine production in these cells,
then Rin-/- animals should display blunting of IL-1β and TNF-α levels following in
vitro stimulation with the TLR4 agonist, lipopolysaccharide.
Clarification of Rin Physiology using a conditional KO mouse model
Herein, we have described how Rin loss alters cell death (Chapter 3),
axonal degeneration (Chapter 4) and inflammatory responses (Chapter 5)
following trauma; however, due to the complex interplay between cells of the
CNS we are unable to determine a primary role for Rin. All the studies presented
in this dissertation were carried out using a whole-body Rin null mouse model,
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and although Rin is believed to be expressed solely in neurons, expression in
other cell types remains a formal possibility. Furthermore, the use of a global
knockout mouse does not allow us to determine whether the phenotypes
observed following injury are due to Rin loss or compensatory effects acquired
throughout the lifetime to counteract for Rin loss. In order to address these
apparent issues, our lab has recently generated conditional KO Rin mice that can
be combined with tamoxifen-induced Cre expression in specific tissues. When
crossed to lines allowing inducible neuronal-selective Cre expression, these mice
will allow neuron specific RIT2 loss (Betz, Vosshenrich et al. 1996). Using these
mice, we can be certain that effects we have observed are specific to the neuron.
Using these mice, several outcomes of this body of work can be revisited
to allow for more definitive answers regarding the protective properties of Rin
loss. First, neuronal specific knockout of Rin would allow us to determine whether
acute blunting of pro-inflammatory cytokine production following CHI (Figure 5.1)
was indeed neuronally based without having to culture glia or immune cells.
Furthermore, these mice will allow us to revisit RAWM testing following mild head
injury (Figure 5.5) to determine whether Rin loss indeed leads to spatial learning
deficits.
Conclusions
The data presented in this dissertation has demonstrated Rin loss to be
neuroprotective in several models of traumatic injury: enhancing mature neuronal
survival, diminishing cognitive decline, decreasing axonal injury, and blunting
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acute pro-inflammatory cytokine production. These data suggest a novel and
unexpected physiological role for Rin in the promotion of neuronal cell death and
axonal degeneration following injury. Further studies are needed to investigate
the contribution of Rin signaling to post-traumatic injury cascades; however,
these initial studies provide evidence of a new avenue of therapeutic intervention
through the inhibition of Rin GTPase.

Copyright © Megan D. Pannell 2017
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Appendix

List of Abbreviations

AF6
ANOVA
APP
Arf
ASF
ATP
BBB
BDNF
BrdU
CA-1
CA-3
CCI
CD45
CD68
Cdc42
CHI
CNS
DA
DAMP
Dcx
DG
DLK
DMEM
EGF
ELISA
ERK
EtOH
FBS
FGF
FJC
GAP
GCS
GDI
GDP
GEF
GFAP
GTP
GTPase

	
  

ALL (acute lymphoblastic leukemia) fused gene on chromosome 6
Analysis of variance
Amyloid precursor protein
ADP-ribosylation factor
Area sampling fraction
Adenosine triphosphate
Blood brain barrier
Brain-derived neurotropic factor
5-bromo-2’-deoxyuridine
Cornu Ammonis area 1
Cornu Ammonis area 3
Controlled cortical impact
Cluster of Differentiation 45
Cluster of Differentiation 68
Cell division control protein 42
Closed head injury
Central nervous system
Dopamine
Damage associated molecular patterns
Doublecortin
Dentate gyrus
Dual leucine zipper kinase
Dulbecco’s modified Eagle’s medium
Epithelial growth factor
Enzyme-linked immunosorbent assay
Extracellular signal related protein kinase
Ethanol
Fetal bovine serum
Fibroblast growth factor
Fluorojade-C
GTPase-activating protein
Glasgow Coma Score
Guanine nucleotide dissociation inhibitor
Guanosine diphosphate
Guanine nucleotide exchange factor
Glial fibrillary acidic protein
Guanosine triphosphate
Guanosine triphosphatase
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GRF
GWAS
IGF-1
IGL
IL-1b
IL-6
IL-10
JIP
JNK
Ki67
KO
MAPK
MAPKK
MAPKKK
MEKK4
MKK2
mTBI
MONS
NAD+
NeuN
NF
NGF
NGS
NDS
NMNAT
NOR
NSS
NT-3
OGL
PACAP38
PAGE
PBS
PC6
PD
PFA
PI3K
PI(3,4,5)P3
PI(4,5)P2
PKC
PTEN
Rab
Rac
Ran
Ras
RAWM
Rho

	
  

Growth hormone releasing factor
Genome-wide Association Study
Insulin-like growth factor- 1
Inner granular layer
Interleukin 1 beta
Interleukin 6
Interleukin 10
JNK-interacting protein
c-Jun N-terminal kinase
Antigen Ki-67
Knock-out
Mitogen-activated protein kinase
Mitogen-activated protein kinase kinase
Mitogen-activated protein kinase kinase kinase
Mitogen-activated protein kinase kinase kinase 4
Mitogen-activated protein kinase kinase kinase 2
Mild traumatic brain injury
Mono-ocular nerve stretch
Nicotinamide adenine dinucleotide
Neuronal Nuclei
Neurofilament
Nerve growth factor
Normal goat serum
Normal donkey serum
Nicotinamide mononucleotide adenylyltransferase 1
Novel Object Recognition
Neurological Severity Score
Neurotrophin-3
Outer granular layer
Pituitary adenylate cyclase activated polypeptide 38
Polyscrylamide gel electrophoresis
Phosphate buffered saline
Pheochromocytoma 6 cell line
Parkinson’s disease
Paraformaldehyde
Phosphatidylinositol-3 kinase
Phosphatidylinositol 3,4,5-triphosphate
Phosphatidylinositol 4,5-bisphosphate
Protein kinase C
Protein and tensin homolog
Ras-related GTP-binding protein
Ras-related C3 botulinum toxin substrate
Ras related nuclear protein
Rat sarcoma
radial arm water maze
Ras homolog gene family
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RhoA
Ric
Rin
RIN1
Rit
RNA
RNAi
ROCK
ROS
RT
RTK
SAPK
Sarm1
SCG10
SDS
SDS-PAGE
SEM
SGZ
SH2
SMI32
Sos1
SSF
TAI
TBI
TBS
TNF-α
TSF
Ube4b
VEGF
Wlds
WT
YFP

	
  

Ras homolog gene family, member A
Ras-related protein which interacts with calmodulin
Ras-related protein in neurons
Ras interaction protein-1
Ras-related protein in tissues
Ribonucleic acid
Ribonucleic acid interference
Rho-associated protein kinase
Reactive oxygen species
Room temperature
Receptor tyrosine kinase
Stress-activated protein kinase
Sterile alpha and TIR containing 1
Superior cervical ganglion-10
Sodium dodecyl sulfate
Sodium dodecyl sulfate poly-acrylamide gel electrophoresis
Standard error mean
Sub-granular zone
Src homology 2 domain
Nonphosphorylated neurofilament
Son of sevenless 1
Selection sampling fraction
Traumatic axonal injury
Traumatic brain injury
Tris buffered saline
Tumor necrosis factor alpha
Thickness sampling fraction
ubiquitination factor e4b
Vascular endothelial rowth factor
Wallerian slow mutant
Wild-type
Yellow Fluorescent Protein
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